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ABSTRACT	
	
A	three-armed,	six-week	randomized	controlled	trial	was	conducted	between	16-
22	weeks	gestation	(baseline)	and	24-28	weeks	gestation	(final).	Previously	sedentary	
women	(n=11)	were	randomized	to	one	of	three	groups	following	baseline:	Group	1)	
Reduce	sedentary	time	(ST)	by	interrupting	prolonged	sitting	(n=5);	Group	2)	Reduce	ST	
via	walking	30	minutes	most	days	of	the	week	(n=3);	or	Group	3)	Continue	with	daily	
routines	(n=3).	Participants	(Groups	1	and	2)	received	Fitbit®	monitors	to	promote	
physical	activity	(PA)	behavior	change.		
Data	was	collected	over	a	7-day	period	during	baseline	and	final.	PA	was	
assessed	with	activPALTM,	Sensewear®	armband,	Fitbit®,	and	PA	record.	Measured	
weight	was	compared	to	the	2009	Institute	of	Medicine	(IOM)	recommended	rate	of	
weekly	weight	gain.	Dietary	intake	was	assessed	using	a	3-day	weighed	diet	record.	
Participants	underwent	a	75-gram	2-hour	oral	glucose	tolerance	test	(final).	
No	significant	differences	were	found;	descriptive	results	are	as	follows.	One	
participant	in	each	group	decreased	ST	from	baseline	to	final	(-3.63%,	-4.07%,	-13.75%,	
per	group,	respectively).	Groups	1	and	2	decreased	ST	in	bouts	>	60	minutes	(152.40	+	
103.34	minutes	baseline,	133.18	+	19.88	minutes	final;	202.55	+	60.51	minutes	baseline,	
175.02	+	89.84	minutes	final,	respectively),	whereas,	Group	3	increased	(203.95	+	92.89	
minutes	baseline,	224.69	+	132.18	minutes	final).	A	moderate	effect	size	was	found	for	
reducing	prolonged	ST	between	intervention	groups	and	Group	3	(0.66).	Group	1,	
decreased	moderate	vigorous	physical	activity	(MVPA)	from	baseline	(132	+	96.16	
minutes)	to	final	(40.5	+	34.64	minutes).	Groups	2	(16.66	+	22.30	minutes	baseline;	
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53.66	+	85.27	minutes	final)	and	3	(UC;	73.33	+	62.26	minutes	baseline;	84.33	+	84.67	
minutes	final)	increased.	A	small	effect	size	was	demonstrated	between	intervention	
groups	and	Group	3	(0.48).		Groups	1	and	2	met	the	intervention	goal	58.4-98.8%	and	0-
213%	of	the	time,	respectively.	A	positive	relationship	for	increased	ST,	higher	fasting,	
60,	120-minute	blood	glucose	levels	and	increased	calorie	consumption	was	found.	
Based	on	the	IOM	guidelines,	one	participant	gained	less,	one	met	and	six	exceeded	
recommendations.	Based	on	preliminary	data,	finding	effective	strategies	to	decrease	ST	
during	pregnancy	remains	important.	
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CHAPTER	1.	INTRODUCTION	
Introduction	
Pregnancy	is	one	of	life’s	most	important	stages,	as	the	health	of	two	human	
lives	is	influenced	by	the	actions	of	one	individual.	Many	researchers	and	healthcare	
workers	have	utilized	this	fact	to	encourage	pregnant	women	to	adopt	healthier	
lifestyles	by	engaging	in	nutritious	eating	and	physical	activity	(PA).1,	2	Among	the	
multitude	of	healthy	factors	women	can	engage	in	during	pregnancy,	PA	has	been	
identified	as	a	contributor	to	a	healthier	pregnancy.3,	4	PA	is	defined	as	any	bodily	
movement	produced	by	the	contraction	of	skeletal	muscle	that	increases	energy	
expenditure	above	a	basal	level,5	whereas	exercise	is	defined	as	an	activity	that	is	
planned,	structured	and	repetitive	with	a	final	goal	of	maintaining	or	improving	physical	
fitness.6		
According	to	the	American	College	of	Obstetricians	and	Gynecologists’	(ACOG)	
committee	opinion,	pregnant	women	should	engage	in	an	exercise	program	that	leads	
to	an	eventual	goal	of	moderate-intensity	exercise	for	at	least	20-30	minutes	per	day	on	
most	or	all	days	of	the	week.7	In	contrast	to	PA,	more	time	spent	sedentary,	commonly	
referred	to	as	sedentary	behavior	(SB)	or	sedentary	time	(ST),	can	have	detrimental	
effects	on	health.	The	topics	of	PA	and	SB	are	independent	of	one	another	but	
frequently	discussed	concurrently.	For	example,	an	individual	can	be	very	physically	
active	and	spend	little	time	in	SB,	be	extremely	inactive	and	spend	the	majority	of	the	
day	sedentary	or	exist	in	any	variation	between	the	two	extremes.	The	pregnant	
population	spends	nearly	75%	of	waking	hours	in	SB	and	approximately	only	16%	of	
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pregnant	women	comply	with	current	PA	recommendations.8,	9		Although	not	as	
intensely	researched	at	this	time,	SB	literature	regarding	pregnant	populations	is	
evolving,	as	research	in	the	non-pregnant	population	demonstrates	that	SB	has	a	
negative	effect	on	metabolic	health	parameters	and	overall	well-being.	To	minimize	SB	
and	associated	health	consequences,	present	research	in	the	non-pregnant	population	
is	focusing	on	interrupting	time	spent	in	prolonged	SB	bouts.10-12		
The	purpose	of	the	BlossomUP	(BUP)	study	focus	was	to	decrease	ST	in	pregnant	
women	with	secondary	outcomes	addressing	the	evaluation	of	PA,	adherence	to	2009	
IOM	weight	gain	guidelines	and	glucose	tolerance.	It	is	our	hypothesis	that	women	
instructed	to	break	up	their	prolonged	ST	will	better	achieve	the	goal	of	decreasing	their	
ST	than	women	instructed	to	engage	in	a	30-minute	walk	on	most	days	of	the	week.		
Thesis	Organization	
This	thesis	includes	an	introduction,	literature	review,	study	methods,	study	
findings	and	conclusion.	Data/findings	(Chapter	3)	from	this	study,	BUP,	will	be	used	as	
preliminary	data	for	a	grant	to	be	submitted	to	the	American	Diabetes	Association	
(ADA).	Figures	are	embedded	within	the	text	and	the	appendices	contain	a	table	
regarding	relevant	ST	and	pregnancy	studies	and	documents	utilized	for	enrollment	and	
data	collection.		
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CHAPTER	2.	LITERAURE	REVIEW	
Physical	Activity	(PA)	Components	
In	addition	to	ACOG	recommendations	of	moderate-intensity	activity	for	at	least	
20-30	minutes	per	day	on	most	or	all	days	of	the	week,	the	U.S.	Department	of	Health	
and	Human	Services	provides	PA	guidelines	for	women	during	pregnancy.	Healthy	
women	should	engage	in	at	least	150	minutes	of	moderate-intensity	activity	each	week.	
These	bouts	of	PA	should	be	accumulated	in	at	least	10	minutes	and	should	be	spread	
throughout	the	week	for	substantial	health	benefits.13	Examples	of	moderate	intensity	
activities	include	brisk	walking,	recreational	swimming	and	bicycling.	Moderate	intensity	
activities	are	given	a	metabolic	equivalent	of	task	(MET)	value	of	3.0-6.0	METs.	Where	
one	MET	is	defined	as	1kcal/kg/hour	and	is	equivalent	to	the	energy	expended	by	an	
individual	sitting	at	rest.	METs	describe	the	energy	cost	of	various	physical	activities	on	
the	body.14	Vigorous	activity	is	assigned	a	MET	value	of	greater	than	6.0	METs	and	
includes	activities	such	as:	paced	swimming	laps	and	jogging	or	running.15	Finally,	the	
term,	leisure	activity	refers	to	activities	such	as	sports	and	exercise,	but	also	household	
tasks	such	as	gardening	and	cleaning.6	
In	regards	to	pregnant	women,	as	earlier	stated,	ACOG	recommends	women	
engage	in	an	exercise	program	that	leads	to	an	eventual	goal	of	moderate-intensity	
exercise	for	at	least	20-30	minutes	per	day	on	most	or	all	days	of	the	week.7	
Recommendations	for	safe	activities	during	pregnancy	include	types	such	as	walking,	
swimming	and	modified	yoga.		
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Although	there	are	benefits	of	PA	during	pregnancy,	such	as	improved	
cardiovascular	function,	management	of	gestational	diabetes	(GDM)	and	limiting	
gestational	weight	gain	16	pregnant	women	are	frequently	not	partaking	in	movement	
beyond	their	daily	routine.	The	National	Maternal	and	Infant	Health	Survey,	
encompassing	9,953	women	from	48	states,	the	District	of	Columbia,	and	New	York	City	
reported	that	approximately	45%	of	women	stated	they	did	not	exercise	at	least	three	
times	a	week	before	or	during	pregnancy	and	13%	exercised	before	pregnancy	but	
stopped	after	they	found	out	they	were	pregnant.17	Further,	in	2000,	data	from	the	
Behavioral	Risk	Factor	Surveillance	System	(BRFSS)	demonstrated	that	34%	of	pregnant	
women	reported	not	engaging	in	any	moderate	or	vigorous	intensity	leisure	activity	
within	the	last	month.18	With	a	concerning	low	number	of	women	engaging	in	PA	during	
pregnancy,	one	must	consider	the	barriers	to	PA.		
Evenson	et	al.	investigated	perceived	barriers	to	PA	during	pregnancy	utilizing	
data	from	two	separate	studies	of	pregnant	women.	Data	from	a	cohort	study	(n=1,535	
women),	the	Pregnancy,	Infection,	and	Nutrition	(PIN)	Study,	found	the	main	barrier	to	
PA	to	be	intrapersonal	and	health-related	(52.1%)	followed	by	intrapersonal	and	non-
health	related	(32.7%)	reasons.	Intrapersonal	barriers	refers	to	factors	that	originate	
within	and	the	individual	has	control	over,	such	as	fatigue	or	lack	of	motivation.19		In	a	
separate	study,	qualitative	data	utilizing	focus	groups	with	58	pregnant	women	with	a	
median	age	of	26	years	old	reveal	the	same	two	barriers	at	the	top	of	the	list.	The	main	
intrapersonal	health-related	barriers	include:	tiredness,	musculoskeletal	problems	and	
shortness	of	breath,	whereas,	intrapersonal	non-health	related	barriers	include	
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examples	such	as:	lack	of	time,	childcare	and	enjoyment	from	PA.20	With	pregnant	
women	reporting	barriers	to	exercise	such	as	not	enough	time	to	engage	in	PA,	
musculoskeletal	problems	triggered	by	PA	and	the	exhaustion	caused	by	physical	
exertion,	a	solution	is	needed	that	will	be	perceived	as	easier,	less	time-consuming	and	
enjoyable.	
SEDENTARY	TIME	(ST):	
ST	introduction	
The	topic	of	ST	has	become	a	newly	explored	area	within	the	last	two	decades	
with	a	lot	of	interest	in	the	last	five	years.21	Appendix	A	highlights	previous	research	
carried	out	regarding	ST	in	pregnancy	within	the	last	11	years.	Current	PA	guidelines	for	
both	pregnant	and	non-pregnant	populations	recommends	only	30	minutes	of	PA	
activity	per	day	on	most	days	of	the	week,	accounting	for	only	2.1%	of	an	entire	day7,	19,	
22	but	it	is	important	to	consider	what	activity	may	or	may	not	be	taking	place	during	the	
remaining	97.9%	of	the	day.23		
The	word	“sedentary”	stems	from	the	Latin	word	‘sedere’,	meaning,	“to	sit”.24	ST	
is	defined	as	any	waking	activity	characterized	by	an	energy	expenditure	of	≤	1.5	METs	
in	a	sitting	or	reclining	posture,	but	does	not	include	sleep.25	ST	refers	to	MET	activities	
requiring	much	less	energy	expenditure	(<1.5	METs)	than	those	of	moderate	or	vigorous	
intensity	activities	(3-6	METs	or	>6	METs,	respectively).	Common	sedentary	activities	
include	television	viewing,	working	at	a	desk,	eating	a	meal	at	a	table	and	driving.25	This	
behavior	is	assessed	via	subjective	measures	(self-	and	proxy-report	questionnaires)	
and/or	objective	measures	such	as	accelerometers	(e.g.,	ActiGraph,	worn	on	the	hip	or	
the	activPALTM,	worn	on	the	front	of	the	thigh).26	27	The	definition	of	“prolonged	ST	(or	
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SB)”,		phrases	commonly	utilized	in	the	sedentary	literature,	is	not	well	defined;	
however	Dunstan	et	al.	describes	this	as	“too	much	sitting”	as	distinct	from	“too	little	
exercise”.11		
ST	in	non-pregnant	adults	
Research	suggests	that	non-pregnant	adults	spend	the	majority	of	days	
sedentary.	Utilizing	an	Actigraph,	data	from	the	2003–2004	National	Health	and	
Nutrition	Examination	Survey	(NHANES)	found	that	participants	spent	7.7	hours	per	day	
(54.9%	of	waking	time)	in	sedentary	activities,	with	females	engaging	in	more	ST	than	
males	throughout	youth	and	early	adulthood.28	Similarly,	a	study	on	528	adults	(30-80	
years	of	age)	found	that	participants	with	newly	diagnosed	type	2	diabetes	mellitus	
(T2DM)	spent	61.7%	of	their	waking	time	in	ST.29		
The	large	percentage	of	hours	spent	sedentary	throughout	the	day	is	concerning,	
as	this	idle	time	has	been	associated	with	negative	health	consequences.	Increased	
prolonged	bouts	of	ST	have	been	independently	associated	with	lower	levels	of	PA	
energy	expenditure30,	31,	increased	risk	of	weight	gain32,	metabolic	syndrome,	diabetes	
and	cardiovascular	disease.33,	34	Specifically,	Wijndaele	et	al.	found	that	ST	(engagement	
in	television	watching	and	computer	activities)	was	positively	associated	with	metabolic	
syndrome	risk	in	men	(P<0.05)	and	women	(P<0.01),	irrespective	of	PA	level.	The	risk	
scoring	took	into	account:	waist	circumference,	triglycerides,	HDL	cholesterol,	blood	
pressure	and	fasting	plasma	glucose.	Categorized	by	age,	time	spent	in	SB	(hours/week)	
included:	14.6	+	8.2	(men	<45	years),	14.9	+	8.1	(men	>	45	years),	11.1	+	6.3	(women	
<45	years),	16.4	+	8.8	(women	>	45	years).35	Furthermore,	a	prospective	study	of	73,743	
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women	enrolled	in	the	Women’s	Health	Initiative	Study	reported	that	women	who	
spent	a	cumulative	16	or	more	hours	per	day	sitting	(assessed	via	detailed	
questionnaire)	had	an	elevated	relative	risk	of	1.68	(95%	confidence	interval,	1.07	to	
2.64)	for	cardiovascular	disease	incidents	(newly	diagnosed	case	of	coronary	disease,	
stroke	and	first	cardiovascular	event)	during	a	six	year	follow-up	compared	with	women	
who	spent	less	than	4	hours	per	day	sitting.36	In	addition,	sitting	while	watching	
television,	while	driving,	at	work	or	away	from	the	home	and	other	sitting	at	home	were	
all	positively	associated	with	incident	T2DM	during	a	six-year	follow-up	among	68,497	
women	from	the	Nurses’	Health	Study.32	Incident	rates	were	obtained	by	dividing	the	
number	of	cases	by	person-years	in	each	category	of	average	time	spent	on	each	
sedentary	activity	(i.e.,	television	viewing).	The	nine	categories	included	zero	
hours/week	up	to	>90	hours/week	of	ST,	reflective	of	greater	than	53%	of	the	day	spent	
sedentary.	Breaking	this	time	up	incrementally,	each	2-hour	block	per	day	of	TV	
watching	was	associated	with	a	23%	increase	in	obesity	and	a	14%	increase	in	diabetes	
risk.	When	this	same	increment	of	time	was	spent	sitting	at	work,	a	5%	increase	in	
obesity	and	7%	increase	in	diabetes	was	exhibited.	Finally,	when	this	time	was	spent	
standing	or	walking	around	the	home	(which	most	likely	reflects	household	work)	a	9%	
reduction	in	obesity	and	a	12%	reduction	in	diabetes	was	shown.32		
Screen-time	has	become	a	major	topic	of	research	as	it	relates	to	ST,	as	a	large	
amount	of	time	in	which	people	engage	in	sedentary	activities	is	spent	in	front	of	the	
television.	In	2007,	a	study	examining	the	associations	of	television	viewing	time	with	
blood	draws	at	two	different	time	points	yielded	interesting	results	in	women.	Blood	
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specimens	were	collected	at	fasting	and	at	2-hours	post-glucose	load	and	television	
viewing	time	was	assessed	via	an	interviewer-administered	questionnaire.	After	
adjusting	for	age,	a	significant	positive	association	between	television	viewing	and	
fasting	plasma	glucose	(FPG)	was	found	(P=0.002).	Additionally,	a	positive,	but	non-
significant	association	was	observed	between	the	television	viewing	and	the	2-hour	
plasma	glucose	levels.	Even	more	specific	and	interesting,	in	age-adjusted	regression	
models,	each	1-hour	per	day	increase	in	television	time	accounted	for	a	0.04mmol/l	
increase	in	FPG	and	a	0.16mmol/l	increase	in	2-hour	plasma	glucose.37		 	
To	further	emphasize	the	detrimental	effects	ST	has	on	glucose	tolerance,	
Henson	et	al.	utilized	ActiGraph	accelerometers	to	measure	ST	in	878	adults	who	were	
at	high	risk	for	T2DM	(including	variables	such	as:	age,	BMI,	sex,	additional	factors	
[family	history,	CVD]).	ST	was	defined	as	<25	counts	per	15	second	epochs	and	a	break	
in	ST	was	defined	as	a	transition	from	sedentary	(<25	counts	per	15	seconds)	to	an	
active	state	(>25	counts	per	15	seconds).	After	adjusting	for	confounders,	ST	exhibited	a	
significant	detrimental	association	with	2-hour	glucose	levels	(p<0.001),	whereas	breaks	
in	ST	were	significantly	inversely	associated	(p=0.046).38	In	summary,	studies	examining	
ST	in	non-pregnant	adults	demonstrated	the	majority	of	days	are	spent	in	ST	and	this	
time	is	associated	with	negative	health	consequences	such	as	metabolic	syndrome,	
cardiovascular	disease,	diabetes	and	obesity.	
ST	in	pregnant	population	
ST	has	been	associated	with	negative	health	consequences	in	non-pregnant	
populations,	but	these	health	consequences	have	not	been	as	thoroughly	investigated	
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during	pregnancy.	Of	importance,	when	women	become	pregnant	they	not	only	
become	less	physically	active	but	also	more	sedentary.	When	comparing	ST	amongst	
non-pregnant	and	pregnant	women	in	a	cross-sectional	study,	pregnant	women	spent	
13%	more	time	sedentary	and	had	44%	lower	total	activity	(counts/day),	as	assessed	by	
Actiheart	accelerometer	data,	than	non-pregnant	women.39	
Furthermore,	current	literature	demonstrates	that	pregnant	women	spend	a	
significant	amount	of	their	waking	time	in	ST.40,	41	In	a	longitudinal	study	evaluating	ST,	
researchers	found	that	pregnant	women	in	their	2nd	and	3rd	trimester	spend	on	average	
75%	of	their	waking	time	in	SB,	as	assessed	by	the	activPALTM.	Further,	women	
increased	ST	from	mid-pregnancy	(week	18)	to	late	pregnancy	(week	35)	(P=0.07).8	
Similarly,	in	a	recent	study	examining	objectively-measured	PA	and	ST	(<1.5	METs)	via	
Fitbit®	monitors	in	pregnancy,	researchers	found	that	ST	progressively	increases	
throughout	pregnancy	with	a	rapid	rate	of	increase	toward	the	end	of	the	nine	
months.42	Not	only	are	women	extremely	sedentary	throughout	their	days,	but	their	
volume	of	ST	increases	with	the	duration	of	pregnancy.	
ST	in	pregnancy	health	consequences		
Although	not	as	thoroughly	researched	in	the	pregnant	population,	ST	during	
pregnancy	has	also	exhibited	negative	health	effects,	similar	to	those	seen	in	non-
pregnant	adults.	One	can	argue	that	this	behavior	may	be	of	greater	concern	during	
pregnancy,	as	this	behavior	has	repercussions	for	two	people.	ST	during	pregnancy	is	
associated	with	adverse	perinatal	health	outcomes	including	abnormal	glucose	
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tolerance,	increased	risk	of	GDM,3	decreased	insulin	sensitivity,	increased	insulin	
secretion	and	excessive	gestational	weight	gain.43		
A	significant	prenatal	complication	with	negative	consequences	for	mother	and	
baby	is	the	risk	of	developing	GDM.	GDM	occurs	when	a	woman	without	diabetes	
develops	high	blood	glucose	levels	during	pregnancy.44	More	specifically,	diagnosis	
occurs	when	one	or	more	of	these	values	from	a	75-gram	oral	glucose	tolerance	test	is	
equal	or	greater	than	the	cut-off:	fasting	blood	glucose:	92mg/dL,	1-hour:	180mg/dL,	2-
hour:	153mg/dL.	This	test,	commonly	referred	to	as	the	one-step	approach,	is	
performed	between	24-28	weeks	gestation	following	an	overnight	fast	and	is	currently	
recommended	by	the	International	Association	of	Diabetes	in	Pregnancy	Study	Groups	
(IADPSG)	task	force	and	the	American	Diabetes	Association	(ADA).45,	46	In	contrast,	
ACOG	currently	recommends	pregnant	women	be	screened	for	GDM	following	the	two-
step	process.	This	includes	a	50-gram,	1-hour	glucose	test.	If	the	50-gram	test	is	positive,	
women	perform	a	100	gram,	3-hour	oral	glucose	tolerance	test	for	possible	GDM	
diagnosis.	Utilizing	the	one-step	process,	16.1%	of	pregnancies	result	in	GDM	diagnosis,	
whereas,	7%	of	pregnancies	results	in	GDM	when	the	two-step	process	is	utilized.45	In	a	
2014	analysis	by	the	CDC	including	reported	Pregnancy	Risk	Assessment	Monitoring	
System	(PRAMS)	questionnaires	and	birth	certificates,	GDM	was	diagnosed	utilizing	a	
mix	of	diagnostic	criteria	including	IADPSG46	National	Diabetes	Data	Group47	and	
Carpenter	and	Coustan48.	This	analysis	yielded	GDM	diagnoses	in	up	to	9.2%	of	
pregnancies	yearly	in	the	United	States.	Its	prevalence	increasing	among	all	ethnic	
groups	since	the	early	1900s,	parallel	to	the	increase	in	T2DM.49,	50		
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GDM	is	of	great	concern	as	the	condition	increases	the	risk	of	fetal	macrosomia,	
neonatal	hypoglycemia,	jaundice,	polycythemia	and	hypocalcemia.51	Further	GDM	is	
associated	with	an	increased	frequency	of	maternal	hypertensive	disorders	and	
cesarean	delivery.51	Halting	this	vicious	cycle	is	crucial	not	only	for	the	short-term	but	
also	the	long-term	considerations	for	the	mother	and	future	newborn.		
Regarding	the	topic	of	GDM,	it	is	important	to	note	that	during	pregnancy,	a	
woman’s	body	undergoes	many	necessary	adaptations	in	order	to	meet	the	energy	
demands	of	the	growing	fetus.	These	adaptations	include:	impaired	insulin	sensitivity,	
increased	beta-cell	response,	increased	blood	glucose	and	changes	in	circulating	
nutrients.52	Impaired	insulin	sensitivity	in	pregnancy	can	lead	to	insulin	resistance,	which	
is	similar	to	the	insulin	resistance	observed	in	T2DM.53	This	insulin	resistance	seen	in	the	
mother,	is	a	physiological	event	favoring	a	necessary	and	adequate	supply	of	glucose	to	
the	fetus.54	Gradmark	et	al.	illustrates	this	difference	in	insulin	resistance	between	
pregnant	and	non-pregnant	women.	Results	from	a	2-hour	OGTT	demonstrated	
significantly	higher	insulin	levels	and	a	larger	glucose	area	under	the	curve	in	pregnant	
women	when	compared	to	non-pregnant	women	indicating	the	presence	of	insulin	
resistance	at	30,	60,	120	minutes	post	glucose	load.	Further,	insulin	sensitivity	was	
found	to	be	significantly	lower	in	pregnant	women	(p=0.016)	than	their	non-pregnant	
counterparts.39		
Despite	insulin	resistance	in	the	mother,	glucose	homeostasis	is	maintained	in	
normal	pregnancies	by	a	naturally	occurring	compensatory	increase	in	insulin	secretion.	
However,	when	beta-cell	secretion	is	no	longer	sufficient	to	compensate	for	the	insulin	
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resistance,	high	blood	glucose	develops	and	thus	GDM	is	diagnosed.55	Women	who	are	
diagnosed	with	GDM	during	their	pregnancy	have	a	3-7	fold	increased	risk	of	developing	
T2DM	within	5	to	10	years	of	delivery.51,52	A	systematic	literature	review	of	28	studies	
published	between	1965	and	2001	examined	the	relationship	between	GDM	and	T2DM	
after	delivery.	T2DM	development	in	these	participants	ranged	from	2.6%	to	over	70%.	
The	variability	in	these	numbers	can	be	accounted	for	with	the	following	reasons:	T2DM	
follow-up	taking	place	anywhere	between	6	weeks	to	28	years	postpartum,	the	varied	
diagnostic	criteria	utilized	for	both	GDM	and	T2DM	and	the	variation	of	exclusion	
criteria	applied	to	each	study.	T2DM	diagnosis	had	an	accelerated	appearance	during	
the	first	five	years	following	delivery	and	appeared	much	slower	after	10	years.56	
As	mentioned	earlier,	the	child	of	a	mother	diagnosed	with	GDM	is	also	placed	at	
risk	for	health	complications	including	obesity,	glucose	intolerance	and	diabetes	during	
late	adolescence	and	young	adulthood.51,57	The	long-term	effects	of	GDM	on	the	
offspring	of	Pima	Indian	women	who	had	and	had	not	been	diagnosed	with	GDM	
yielded	interesting	results.	The	mothers	who	were	categorized	as	obese	(30-34kg/m2),	
their	children	at	5-9	years	old	exhibited	the	following	outcomes:	12.9%	of	the	offspring	
born	to	mothers	who	did	not	have	GDM	or	were	considered	pre-diabetic	were	obese,	
whereas,	25%	of	the	offspring	born	to	mothers	with	GDM	were	obese	(defined	as	at	
least	140%	of	desirable	weight).	At	10-14	years,	mothers	who	did	not	have	GDM	but	had	
prediabetes,	only	25.7%	of	their	offspring	were	obese,	while	41.7%	of	the	offspring	were	
obese	whose	mothers	were	diagnosed	with	GDM.	Finally,	at	15-19	years	of	age,	the	
comparison	of	obese	offspring	is	vastly	different--23.2%	versus	57.1%	of	offspring	
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categorized	as	obese	with	the	offspring	of	women	without	GDM	and	with	GDM,	
respectively.58	This	study	demonstrates	that	children	born	to	mothers	who	were	obese	
and	diagnosed	with	GDM	during	pregnancy	were	more	likely	to	be	obese	than	children	
born	to	mother	who	were	obese	but	did	not	have	GDM.	In	a	similar	study	with	Pima	
Indians,	complications	of	pregnancy	as	a	function	of	a	2-hour	plasma	glucose	
concentration	following	ingestion	of	a	75-gram	glucose	beverage	was	assessed.	A	total	
of	55.5%	of	women	with	a	2-hour	plasma	glucose	of	>200mg/dL	experienced	perinatal	
mortality	or	an	infant	who	was	large	for	gestational	age,	whereas	only	18.1%	of	women	
with	a	glucose	level	of	<140mg/dL	experienced	these	two	complications.	Additionally,	
44.4%	of	women	with	a	glucose	level	of	>200mg/dL	experienced	toxemia	and/or	a	C-
section,	whereas	only	23.6%	of	women	experienced	either	or	both	of	these	
complications	when	plasma	glucose	was	<140mg/dL.59	According	to	the	one-step	
approach,	a	2-hour	plasma	glucose	level	of	200mg/dL	exceeds	the	cut-off	of	153mg/dL,	
indicative	of	GDM	diagnosis,	whereas,	140mg/dL	is	within	normal	limits.	
As	mentioned	earlier,	women	diagnosed	with	GDM,	are	more	likely	to	deliver	
macrosomic	infants	(>4000g).	The	growing	fetus	receives	a	greater	amount	of	glucose	
which	is	stored	as	excess	body	fat,	leading	to	fetal	macrosomia.	In	a	recent	study	
following	women	into	their	third	trimester,	women	were	predicted	to	either	deliver	
macrosomic	(>4000g)	infants	or	infants	<4000g.	Predictions	were	based	on	ultrasound	
measurement,	abdominal	palpations	and	if	the	woman	had	given	birth	to	a	previous	
macrosomic	infant.	Women	who	spent	significantly	more	time	(16.1	+	2.8	hours)	
sedentary	defined	as	<	1	MET	were	more	likely	to	deliver	macrosomic	infants	as	
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compared	to	women	who	spent	less	time	sedentary	(13.8	+	4.3	hours;	p=.002).	This	is	
concerning,	as	fetal	macrosomia	is	in	turn	associated	with	future	increased	risk	of	
obesity	and	breast	cancer	in	the	offspring	later	in	life.23		
The	topic	of	ST	and	the	development	of	glucose	intolerance	during	pregnancy	is	
becoming	a	newly	researched	area.	A	prospective	cohort	of	1,231	Latina	women	using	a	
non-fasting	50-gram	1-hour	OGTT,	examined	the	associations	between	ST	and	glucose	
tolerance.	Utilizing	the	Kaiser	Physical	Activity	Survey,	women	who	were	categorized	in	
the	highest	tertile	of	ST	during	mid-pregnancy,	a	variable	taking	into	account	TV	
watching,	time	spent	sitting	at	work	and	no	participation	in	sports/exercise	experienced	
significantly	higher	glucose	levels	(3rd	(most	sedentary)	vs.	1st	tertile	(least	sedentary):	
β=0.08	(log	scale),	P=.038)	at	1-hour	than	those	who	engaged	in	the	lowest	total	ST.	
However,	ST	in	pre-pregnancy	and	early	pregnancy	were	not	significantly	associated	
with	glucose	levels.60	Similarly,	a	cohort	study	utilizing	PA	questionnaire	data	from	
Project	Viva	demonstrates	that	a	sedentary	lifestyle,	defined	in	this	study	as	2	or	fewer	
weekly	hours	of	total	PA	(time	spent	walking	and	light,	moderate	and	vigorous	activity)	
during	pregnancy	is	associated	with	abnormal	glucose	tolerance	(OR	1.71,	95%	CI	1.07-
2.73)	and	risk	for	GDM	(OR	2.11,	95%	CI	1.01-4.40).3	Abnormal	glucose	tolerance	in	this	
study	was	defined	as	those	who	failed	the	non-fasting	50-gram	OGTT.		The	
aforementioned	studies	exhibit	the	adverse	health	implications	such	as	GDM	and	
potential	T2DM	for	mother	and	child	and	fetal	macrosomia	when	time	is	spent	
sedentary	during	pregnancy.		
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ST	and	weight	gain		
In	regards	to	overall	health	during	pregnancy,	the	gestational	weight	a	woman	
gains	can	have	immediate	and	long-term	consequences	for	the	woman	and	her	child.	In	
2009,	the	Institute	of	Medicine	(IOM)	published	updated	gestational	weight	gain	(GWG)	
guidelines	that	are	based	on	pre-pregnancy	body	mass	index	(BMI)	ranges	for	
underweight,	normal	weight,	overweight	and	obese	women	that	encompass	both	total	
and	rate	of	weight	gain	during	pregnancy.61	These	recommendations	provide	a	clinical	
basis	for	weight	gain	during	pregnancy	that	physicians	can	utilize	to	provide	
individualized	care	to	patients.	
Table	1.	2009	Recommendations	for	Total	and	Rate	of	Weight	Gain	During	Pregnancy,	
by	Pre-pregnancy	BMI	
Pre-pregnancy	BMI	 BMI	(kg/m2)	
(WHO)	
Total	Weight	Gain	
Range	(lbs)	
Rates	of	Weight	
Gain	2nd	and	3rd	
Trimester	(Mean	
Range	in	lbs/wk)*	
Underweight	 <18.5	 28-40	 1	(1-1.3)	
Normal	weight	 18.5-24.9	 25-35	 1	(0.8-1)	
Overweight	 25.0-29.9	 15-25	 0.6	(0.5-0.7)	
Obese	(includes	all	
classes)	
>30.0	 11-20	 0.5	(0.4-0.6)	
*Calculations	assume	a	0.5-2kg	(1.1-4.4	lbs)	weight	gain	in	the	first	trimester	(based	on	
Siega-Riz	et	al.,	1994;	Abrams	et	al.,	1995;	Carmichael	et	al.,	1997)62		
	
If	a	woman	exceeds	her	targeted	recommended	range	of	total	weight	gain	
during	pregnancy,	the	woman	is	said	to	have	gained	in	excess,	otherwise	referred	to	as	
excessive	gestational	weight	gain	(EGWG).	This	also	holds	true	for	the	rate	of	gain	during	
the	2nd	and	3rd	trimesters	of	pregnancy.	EGWG	increases	risk	of	macrosomia,	
postpartum	weight	retention,	future	maternal	obesity	and	possibly	future	childhood	
obesity.62	In	a	study	conducted	by	Deputy	et	al.,	68%	of	the	women	enrolled,	
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representative	of	28	states	from	the	Pregnancy	Risk	Assessment	Monitoring	System	
project,	gained	more	than	their	recommended	amount	of	weight	set	forth	by	the	2009	
IOM	guidelines,	placing	them	in	the	“excessive”	weight	gain	category.	According	to	
combined	state-specific	CDC	data	from	2013	and	PRAMS	data	from	2012,	only	32.1%	
(range	=	26.2-39%)	of	women	gained	within	the	IOM	recommendations,	12.6-	25.5%	
gained	inadequately,	while	the	prevalence	of	EGWG	ranged	from	38.2-54.7%.63	Further,	
the	prevalence	of	EGWG	was	>	50%	in	17	states.64	Simas	et	al.	report	similar	findings—
52.6%	of	all	pregnant	women	gaining	in	excess	with	even	more	pronounced	outcomes	in	
women	who	are	overweight	or	obese,	with	68.9%	and	59.8%	gaining	in	excess,	
respectively.65	
The	understanding	of	the	relationship	between	time	spent	sedentary	and	the	
influence	on	weight	gain	during	pregnancy	is	limited	and	requires	further	research.66	In	
a	secondary	data	analysis	evaluating	the	relationship	of	ST	and	GWG,	no	significant	
associations	were	found	between	the	reduction	of	ST	during	pregnancy	leading	to	a	
reduction	of	EGWG.	However,	the	researchers	note	the	findings	from	this	study	are	new	
and	the	literature	still	young,	confirming	more	studies	with	randomized	designs	should	
be	carried	out.	Additionally,	studies	focusing	on	non-pregnant	women	and	adolescent	
girls	yield	results	demonstrating	a	relationship	between	ST	and	weight	gain	exist.	In	a	
recent	review	of	33	studies	regarding	the	relationship	between	ST	and	health	indicators	
in	adolescent	girls	(12-18	years	old),	17	out	of	19	(89%)	studies	focusing	on	weight	
status	found	an	overall	positive	association	between	screen-based	ST	and	weight	status,	
particularly	when	screen	time	exceeded	2	hours	per	day.67	As	previously	mentioned,	a	
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multitude	of	the	sedentary	literature	is	based	on	television	viewing,	as	television	
viewing	is	considered	a	proxy	for	ST.	The	findings	from	this	review	are	concerning	
because	if	ST	during	adolescence	is	associated	with	increased	body	weight,	these	habits	
are	likely	to	track	into	adulthood.	In	contrast,	two	studies	within	the	review	reported	
the	reduction	of	overall	screen-based	ST	is	associated	with	lower	weight.68	69	Specifically,	
less	than	4	hours	of	screen	time	per	week	reduced	the	risk	of	obesity	by	40%.69	
In	2003,	Hu	et	al.	assessed	exercise	levels	via	questionnaire	asking	participants	
how	much	time	they	spent	during	the	week	in	the	following	activities:	walking,	jogging,	
running,	biking,	aerobics,	lap	swimming,	racquetball	and	tennis	and	their	typical	walking	
pace.	Independent	of	exercise	levels,	ST,	specifically	television	viewing	was	associated	
with	a	significant	elevated	risk	of	obesity.	A	23%	(95%	CI,	17-30%)	increase	in	obesity	
risk	accompanied	each	2-hour/day	increase	in	time	spent	watching	TV.	In	a	multivariate	
analysis,	participants	who	accumulated	the	least	METs	per	week	(assessed	by	
participant	report	of	amount	of	time	spent	in	activity	per	week	and	walking	pace	per	
week)	and	were	the	most	sedentary	(>20	hours/week	of	television	viewing)	had	a	
significant	increased	risk	of	obesity	(RR,	1.90;	95%	CI,	1.61-2.24)	compared	to	those	with	
the	most	METs	per	week	and	lowest	television	viewing	time	(<6	hours/week).32		
Overall,	EGWG	is	considered	a	mounting	issue	and	one	that	researchers	and	
healthcare	workers	have	increasingly	strategized	to	combat.	Although	not	heavily	
studied	in	the	pregnant	population,	optimism	is	present	that	modest	reductions	in	ST	
may	also	benefit	this	population.	
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Breaking	up	prolonged	ST	with	walking	
During	pregnancy,	total	PA	is	positively	associated	with	insulin	sensitivity	(r=0.28;	
95%	CI,	-0.07-0.57).39	This	suggests	that	increased	movement	and	PA	at	any	intensity,	
not	just	moderate-vigorous	PA,	including	short,	walking	breaks	to	break	up	prolonged	
ST,	may	aid	in	controlling	and	maintaining	glucose	homeostasis	during	pregnancy.		
In	addition	to	the	effects	of	total	ST,	the	manner	in	which	it	is	accumulated	may	
also	be	important.	Dunstan	et	al.	examined	overweight/obese	adults’	plasma	glucose	
and	serum	insulin	levels	following	consumption	of	a	200	mL	standardized	test	drink	
simulating	a	mixed	meal	(75-grams	carbohydrate,	50-grams	fat	and	0-grams	protein).	
Metabolic	biomarkers	were	evaluated	when	participants	remained	seated,	
uninterrupted	for	5	hours	or	seated	with	2-minute	bouts	of	light	or	moderate-intensity	
walking	every	20	minutes.	In	this	crossover	study,	participants	who	engaged	in	a	light-
intensity	walk	every	20	minutes	experienced	a	24.1%	(P<0.01)	lower	glucose	response	
than	those	who	continually	sat.	A	moderate-intensity	walk	every	20-minutes	resulted	in	
a	glucose	response	that	was	29.6%	(P<0.0001)	lower	than	uninterrupted	sitting.	Both	
walking	groups	displayed	a	23%	(P<0.0001)	reduction	in	their	insulin	area	under	the	
curve	(iAUC;	incremental	area	under	the	curve)	relative	to	the	uninterrupted	sitting	
group.11		These	findings	suggest	that	by	including	brief	bouts	of	activity	regardless	of	
intensity	during	prolonged	ST,	plasma	glucose	concentrations	and	serum	insulin	
response	may	be	more	tightly	controlled.		
To	further	demonstrate	the	beneficial	effects	on	metabolic	risk	variables	by	
interrupting	prolonged	ST,	Healy	et	al.	demonstrated	in	a	cross-sectional	study	that	
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frequent	breaks	in	ST	were	beneficially	associated	with	a	lower	BMI	(P=.026)	and	lower	
75-gram,	2-hour	plasma	glucose	levels	(P=0.025).	Participants	in	the	highest	quartile	of	
ST	breaks	exhibited	a	0.88	mmol/L	lower	2-hour	glucose	level	than	those	in	the	lowest	
quartile.	Cut	points	for	quartiles	includes:	506,	612	and	673	total	breaks.	On	average,	
breaks	were	less	than	five	minutes	in	duration	(4.50	+	1.05	minutes)	and	categorized	as	
light	intensity	(accelerometer;	514	+	94	counts/min),	suggesting	that	something	as	
simple	as	getting	up	during	television	commercials	or	walking	to	the	restroom	at	work	
can	have	beneficial	metabolic	health	implications.70		Comparatively,	another	study	
conducted	by	Healy	and	colleagues	found	that	walking	breaks	as	short	as	one	minute	
can	result	in	lower	waist	circumferences	and	fasting	plasma	glucose	levels.	Individuals	
who	ranked	in	the	top	quartile	of	breaks	in	ST,	had	a	4.1	cm	smaller	waist	circumference	
and	a	0.04	mmol/L	reduction	in	fasting	plasma	glucose	than	those	in	the	lowest	
quartile.12		(Quartile	cut	points	for	total	breaks	in	ST:	470,	559	and	645).	
In	addition	to	walking	breaks,	research	has	examined	the	impact	of	standing	
breaks.	A	randomized	cross-over	trial	conducted	by	Bailey	et	al.	analyzed	data	from	non-
obese	adults	and	the	effects	of	three-treatment	trials	including:	uninterrupted	sitting;	
seated	with	2	minute	bouts	of	standing;	or	2	minute	bouts	of	light	intensity	walking	
every	20	minutes.	Each	trial	lasted	five	hours	and	with	at	least	six	days	between	each	
treatment,	ensuring	no	carry-over	effects	from	the	previous	trial.	All	trials	were	
conducted	after	the	ingestion	of	test	drinks	(80.3-grams	carbohydrate,	50-grams	fat	and	
0-grams	protein).	In	regards	to	glucose	AUC,	researchers	found	that	sitting	paired	with	
2-minute	walking	bouts	every	20	minutes	significantly	lowered	glucose	response	by	
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15.9%	(20.0mmol	L/5-h,	p<0.001)	as	opposed	to	uninterrupted	sitting	(23.5	mmol	L/5-h)	
and	sitting	with	the	2-minute	standing	bouts	which	lowered	glucose	response	by	16.7%	
(23.7mmol	L/5-h).	It	should	be	noted	that	interrupting	sitting	time	with	short	bouts	of	
light-intensity	activity	assists	in	lowering	postprandial	glycemia	in	non-obese	adults.10		
Although	short	frequent	bouts	of	standing	had	no	significant	effect	on	glucose	response	
over	a	five-hour	period.		
In	another	randomized	trial,	researchers	examined	the	effects	of	reducing	
workplace	ST	via	utilization	of	a	height-adjustable	desk	during	the	workday	on	
postprandial	glucose	response	in	overweight/obese	adults	(BMI	>25kg/m2).	Participants	
underwent	two,	five	consecutive-day	experimental	conditions	with	a	minimum	of	a	
week	between	each	trial.	The	control	consisted	of	participants	performing	usual	
workday	activities	in	a	seated	posture	for	eight	hours	per	day	and	only	walked	for	
restroom	use.	The	intervention	participants	performed	usual	workday	activities,	
however,	they	were	instructed	to	alternate	between	a	seated	and	standing	position	
every	30	minutes	of	the	eight	total	hours	(equivalent	to	four	cumulative	hours	of	
standing	and	four	hours	of	sitting	daily).	A	fasting	venous	blood	sample	was	collected	
prior	to	consumption	of	a	mixed	test	drink	(75-grams	carbohydrate,	50-grams	fat,	0-
grams	protein)	and	initiation	of	the	eight-hour	work	day	each	day	for	the	five-day	
period.	Blood	samples	were	then	collected	at	60,	120,	180	and	240-minutes	post	meal	
ingestion.	At	the	end	of	the	4-hour	blood	collection,	participants	were	fed	a	lunch	meal;	
all	other	meals	for	the	five-day	period	were	developed	and	prepared	by	a	registered	
dietitian	to	minimize	diet	variability.	A	significant	(P=0.007)	11.1%	reduction	in	glucose	
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incremental	area	under	the	curve	(iAUC)	during	the	prolonged	sitting	with	intermittent	
30	minute	standing	was	observed,	however	no	significant	differences	were	observed	on	
serum	insulin.71	
In	regards	to	ST	in	pregnancy,	Di	Fabio	et	al.	found	the	number	of	transitions	
between	sedentary	activity	to	upright	activity	increases	significantly	by	27%	(P=.002)	
from	mid	to	late	pregnancy	suggesting	that	women	increase	interruptions	in	prolonged	
ST	as	pregnancy	advances.41	Although	engaging	in	PA	and	reducing	ST	may	have	
different	health	implications,	partaking	in	one	may	be	better	than	nothing	at	all.	
Furthermore,	towards	the	end	of	pregnancy,	women	are	more	likely	to	feel	
uncomfortable	and	increase	the	frequency	of	breaks	from	ST	as	pregnancy	advances.	
Interventions	that	focus	on	reducing	prolonged	ST	may	be	a	more	attainable	and	viable	
option	compared	to	intentional	PA	participation.	Future	pregnancy	interventions	that	
aim	to	reduce	prolonged	ST	may	be	more	successful	at	improving	maternal	and	fetal	
outcomes	such	as	glucose	tolerance,	appropriate	weight	gain	and	increasing	time	spent	
moving	more	so	than	interventions	targeted	at	increasing	PA	levels.20,	42,	72	
PA	and	inactivity	relationship	
With	respect	to	decreasing	ST,	PA	can	almost	be	recognized	as	the	antagonist.	
An	individual	who	sleeps	eight	hours	per	day	has	a	remaining	16	hours	to	carry	out	
domestic	and	work	duties.	Depicting	a	typical	day,	this	individual	wakes	up	at	7am	and	
immediately	engages	in	45	minutes	of	purposeful	PA,	fulfilling	the	current	PA	guidelines	
of	30	minutes	per	day	on	most	days	of	the	week.	22	Following	this	exercise	bout,	the	
adult	drives	to	work,	works	on	the	computer,	eats	lunch,	continues	to	work,	drives	
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home,	eats	dinner	and	then	relaxes	while	watching	TV—all	of	which	are	sedentary	
activities.	Although	it	is	evident	that	the	majority	of	this	individual’s	time	is	spent	sitting,	
he/she	would	classify	him/herself	as	physically	active,	as	current	PA	guidelines	consider	
this	adult	“physically	active”,	yielding	the	phrase	“active	couch	potato”.73	The	active	
couch	potato	phenomenon	is	described	as	the	coexistence	of	high	ST	and	achievement	
of	PA	recommendations.21	This	may	lead	to	adverse	thinking	that	since	the	daily	PA	
requirement	for	the	day	was	met,	the	rest	of	the	day	can	be	spent	in	sedentary	
activities.		
The	Blossom	Project	demonstrates	this	same	phenomenon	among	pregnant	
women.	A	total	of	44	women	were	randomized	to	either	a	walking	intervention	(n=23)	
to	increase	walking	or	a	usual	care	group	(n=21)	that	was	asked	to	continue	on	with	
their	normal	daily	routine.	At	mid-pregnancy	(week	26),	walking	in	more	than	10	minute	
bouts	(P=0.002)	and	intentional	walking	(P=<0.01),	defined	as	>20	minutes,	was	greater	
in	the	intervention	than	in	the	usual	care	group.	Unfortunately,	the	increased	walking	
came	with	an	unfavorable	outcome,	women	who	increased	their	intentional	walking	
spent	more	of	their	day	sedentary	(70.9%	total	ST,	P=0.026)	and	spent	more	time	in	
sedentary	activities	for	bouts	greater	than	30	minutes	(371.8	+	122.9	minutes	per	day	in	
bouts	>	30	minutes,	P=0.024)	than	those	who	did	not	increase	their	intentional	walking	
(65.33%	total	ST,	285.7	+	90.6	minutes	per	day	in	bouts	>30	minutes).74	This	suggests	
that	when	women	increased	intentional	walking,	more	time	was	spent	sedentary	and	in	
bouts	greater	than	30	minutes.		
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When	daily	fulfillment	of	current	PA	guidelines	is	achieved,	but	the	rest	of	the	
day	is	spent	sedentary,	can	a	desirable	health	status	be	maintained?	Peddie	et	al.		
studied	70	healthy,	normal	weight	adults	in	a	randomized	crossover	study	comparing	
the	effects	of	prolonged	sitting	for	nine	hours	versus	a	single	30-minute	walk	followed	
by	prolonged	sitting	versus	short	(1	minute	40	second	every	30	minutes)	walks	
interrupting	prolonged	sitting	on	postprandial	glycemia	and	insulinemia.	Meal-
replacement	beverages	(1.12-grams	carbohydrate,	0.46-grams	fat,	0.54-grams	protein	
per	kg	body	weight)	were	provided	at	the	1,	4	and	7-hour	marks.	Each	participant	
provided	16	blood	samples.	A	fasting	venous	sample,	a	sample	from	each	hour	between	
baseline	and	the	nine-hour	mark	and	six	additional	samples	at	30	and	45-minutes	post	
beverage	consumption.	Results	of	glucose	and	insulin	iAUC	are	as	follows,	respectively:	
prolonged	9-hour	sitting:	48.8mmol/L	(95%	CI,	40.7-57.0);	3337.0IU/L	(95%	CI,	2783.4-
3890.6),	continuous	30-minute	walk:	47.2mmol/L	(95%	CI,	39.1-55.4);	3012.3IU/L	(95%	
CI,	2460.5-3564.1),	short	activity	breaks:	29.9mmol/L	(95%CI,	21.8-38.0);	2470.3IU/L	
(95%	CI,	1919.6-3021.0).		With	respect	to	the	short	activity	breaks,	glucose	and	insulin	
iAUC	were	significantly	different	(P<0.001)	from	the	prolonged	sitting	and	continuous	
30-minute	walk	values	(insulin	iACU,	P=0.003).	These	results	support	the	idea	that	short	
activity	breaks	throughout	the	day	may	be	more	beneficial	to	health	than	a	single	
continuous	30-minute	bout	of	PA	or	continuous	sitting	for	nine-hours,	specifically	at	
lowering	postprandial	glucose	and	insulin	concentrations.75		
The	importance	of	PA	cannot	be	overlooked.	Accumulating	evidence	
demonstrates	the	physiological	responses	of	decreasing	ST	are	different	from	the	
		
24	
responses	of	engaging	in	PA,	and	that	both	play	an	important	role	in	determining	
metabolic	health.16,	17,	20	In	a	study	conducted	by	Dempsey	et	al.	women	who	engaged	in	
recreational	PA	during	the	first	20	weeks	of	pregnancy	experienced	a	48%	reduced	risk	
of	GDM	compared	to	women	who	were	inactive	during	this	early	pregnancy	period	
(OR=0.52;	95%	CI	0.33-0.80).76	Similarly,	Dempsey	et	al.	via	questionnaire	interviews,	
reported	women	who	spent	>6.0	hours	per	week	during	pregnancy	engaged	in	PA	were	
58%	less	likely	than	women	who	were	inactive	to	develop	GDM	(RR=0.42,	95%	CI:	0.19-
0.97).77	In-person	interviews	were	carried	out	when	the	mean	gestational	age	of	
participants	was	12.7	weeks.	Similarly,	Dye	et	al.	reported	that	inactivity	during	
pregnancy	was	associated	with	a	1.9-fold	increased	risk	of	GDM	(OR=1.9;	95%	CI	1.2-
3.1).78		
Both	PA	and	ST	have	important	health	implications.	However,	ST	may	be	a	more	
important	indicator	of	health	than	moderate-vigorous	physical	activity	(MVPA),	since	ST	
occupies	the	majority	of	the	day,	unlike	MVPA.38	Based	on	these	findings,	it	may	be	
more	beneficial	to	focus	on	the	amount	of	ST	and	work	to	decrease	this	behavior	as	
opposed	to	increasing	PA	time.			
Conclusion	
As	outlined,	limited	data	regarding	relationships	including	ST	associations	with	
weight	gain,	PA	and	glucose	intolerance	have	been	addressed	in	the	pregnancy	
literature.	The	extent	of	associated	negative	health	outcomes	and	interventions	
focusing	on	breaking	up	prolonged	ST	need	to	be	further	addressed	and	more	
extensively.	Studies	in	the	non-pregnant	population	demonstrate	that	reducing	ST	has	
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the	potential	to	reduce	the	detrimental	health	effects	of	this	behavior.	Future	studies	
assessing	this	relationship	during	pregnancy	are	needed,	as	lifestyle	choices	have	
repercussions	for	two	individuals	including:	EGWG,	glucose	intolerance	and	decreased	
insulin	sensitivity	leading	to	GDM	with	possible	T2DM	diagnosis	for	mother	and	baby	in	
future	years.		
Research	in	non-pregnant	populations	demonstrate	breaking	up	total	ST	with	
short	bouts	of	walking	or	standing	are	helpful	at	decreasing	total	ST	and	thus	negate	the	
side	effects	associated	with	this	behavior.10-12	As	previously	noted,	pregnant	women	
spend	the	majority	of	their	waking	hours	sedentary,	making	strategies	and	best	
methods	in	which	to	decrease	ST	in	pregnancy	a	research	priority.	The	goal	of	BUP,	the	
research	study	described	in	this	thesis,	was	to	determine	the	best	method	in	which	to	
decrease	ST.	While	ST	research	continues	to	evolve,	words	by	Henson	and	colleagues,	
should	remain	in	the	forefront,	“when	sitting,	stand	when	possible;	when	standing,	walk	
or	employ	purposeful	movement	where	possible”.79
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CHAPTER	3.	METHODS	
	
Study	
The	study	described	in	this	thesis	was	completed	in	The	Blossom	Project	Lab.	The	
overall	goal	of	the	Blossom	Project	at	Iowa	State	University	(ISU)	is	to	improve	the	lives	
of	pregnant	women	and	their	children	through	encouraging	PA	and	healthful	eating	
during	pregnancy.	As	part	of	The	Blossom	Project’s	goal	and	to	contribute	to	filling	the	
research	gap	regarding	ST	in	pregnancy,	BlossomUP,	a	component	of	the	Blossom	
Project,	was	a	three-armed,	randomized	controlled	trial	with	the	primary	purpose	of	
decreasing	ST	in	previously	inactive	pregnant	women	with	secondary	outcomes	
addressing	the	evaluation	of	PA,	calorie	consumption,	glucose	tolerance	and	adherence	
to	the	2009	IOM	weight	gain	guidelines.	Data	collection	occurred	over	a	one-year	
period.	The	University’s	institutional	review	board	approved	the	study.		
Participants	
Healthy	pregnant	women	living	in	the	communities	in	and	around	Ames,	Iowa	
were	recruited	to	participate	in	BUP.	Recruitment	efforts	included	local	obstetric	clinic	
partnerships,	posting	fliers	around	the	community,	Craigslist	and	Facebook	postings,	
and	distributing	campus-wide	emails.	Women	were	recruited	for	this	study	between	
weeks	16-22	gestation.	Inclusion	criteria	included	18-45	years	of	age,	low-active	or	
sedentary	lifestyle	prior	to	pregnancy	(defined	as	less	than	three,	30-minute	intentional	
exercise	sessions	per	week)	and	a	BMI	less	than	40kg/m2.	Exclusion	criteria	included	
being	pregnant	with	more	than	one	baby,	a	smoker,	and	history	of	type	1	diabetes	
mellitus,	heart	disease	or	renal	disease.		
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Study	Design	
The	total	length	participants	were	enrolled	in	this	study	was	six	weeks;	data	was	
collected	at	weeks	16-22	gestation	(baseline)	and	24-28	of	gestation	(final)	(Figure	1).	
Participants	were	randomized	to	one	of	three	groups	after	baseline.	These	groups	
included:	Group	1	(Idle)	women	were	asked	to	decrease	ST	with	the	assistance	of	the	
Fitbit®	Alta	as	a	self-monitoring	behavior	change	tool;	Group	2	(Walk)	women	were	
asked	to	accumulate	150	minutes	of	moderate-vigorous	PA	per	week,	the	current	
pregnancy	PA	recommendation,	using	the	Fitbit®	Charge	to	record	the	goal;	Group	3	
(Usual	Care;	UC)	women	were	asked	to	continue	with	normal	daily	routines	and	
received	no	form	of	intervention.		
	
	
	
	
	
	
	
	
		
	
Figure	1	-		BUP	Study	Timeline	
Abbreviations:	Ht:	height;	Wt:	Weight;	PA:	Physical	Activity;	2-hr:	Two-hour	
28	
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Data	Collection	
At	enrollment,	each	participant’s	height	(cm)	and	weight	(kg)	was	measured,	the	
consent	form	was	signed	and	a	medical	history	questionnaire	was	completed.	
Participants	provided	consent	for	Blossom	Project	staff	to	communicate	with	the	
participant’s	obstetric	provider	to	confirm	eligibility	requirements.	In	addition,	
participants	provided	consent	for	the	research	staff	to	request	weight	from	the	
participant’s	first	prenatal	appointment	(obtained	to	calculate	weight	gain	since	the	
participant’s	first	obstetric	appointment).	These	forms	were	faxed	and	completed	by	the	
obstetric	provider	and	faxed	back	to	the	Blossom	Project	staff.		
Data	collection	occurred	prior	to	randomization	(between	weeks	16-22	
gestation;	baseline)	and	post-intervention	(between	weeks	24-28	gestation;	final).		
During	data	collection,	participants	were	provided	verbal	and	written	instructions	as	to	
how	to	wear	two	PA	monitors	(SenseWear®	armband;	SWA®,	activPALTM;	APTM)	for	a	
seven-day	PA	assessment.	A	Fitbit®	tracker	was	also	worn	during	data	collection,	but	
was	not	utilized	as	a	PA	monitoring	assessment	tool.	A	written	PA	record	was	also	
completed	by	participants	during	the	seven-days	of	monitor	wearing.	Finally,	
instructions	were	provided	regarding	diet	data	collection	(three-day	weighed	diet	
record)	for	three	days	of	the	seven-day	PA	assessment.		
At	final,	weight	was	measured	and	the	aforementioned	instructions	were	
repeated	regarding	the	PA	assessment	and	three-day	weighed	diet	record.	Additionally,	
a	2-hour,	75-gram	oral	glucose	tolerance	test	was	performed	to	assess	glucose	
tolerance.		
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Intervention	
Following	the	seven-day	baseline	data	collection,	participants	were	randomized	
to	one	of	three	groups.	Randomization	was	done	using	Microsoft	Excel.	Participant	
codes	were	listed	in	column	D	and	1’s,	2’s	and	3’s	were	written	every	other	row	in	
column	C.	The	randomization	function	of	excel	(RAND())	was	put	into	every	A	column’s	
cell.	Column	A	values	were	then	pasted	into	column	B	and	both	columns	were	
highlighted.	Utilizing	the	“sort	and	filter”	feature	from	smallest	to	largest	in	column	B	
and	filling	in	column	C	cells	with	black,	participants	were	then	randomized.	Following	
baseline	data	collection	and	prior	to	randomization,	the	participant’s	group	number	
(Group	1,	2	or	3)	was	revealed.			
Group	1	(Idle)	was	asked	to	decrease	ST,	by	walking	250	steps	per	hour	for	12	
hours	per	day.	Participants	in	this	group	received	a	Fitbit®	Alta	activity	tracker,	worn	on	
the	non-dominant	wrist	for	the	entire	intervention.	The	Alta	is	a	fitness	tracker	designed	
to	help	individuals	track	their	sedentary	and	PA	behaviors	when	paired	with	an	external	
device	(e.g.	iPhone,	computer).80	Each	participant	had	a	Fitbit®	account	set	up	with	a	
Blossom	Project	username	code	to	ensure	privacy	of	the	participant's	identity.	
Participants	were	asked	to	achieve	a	goal	of	250	steps	per	hour	for	12	hours	per	day	for	
the	duration	of	the	four-week	intervention.	Participants	could	choose	the	12	hours	in	
which	they	wanted	the	Fitbit®	to	be	activated	(based	on	typical	waking	and	sleeping	
times).	Using	the	"reminder	to	move"	function,	if	a	participant	had	not	reached	the	
hourly	step	goal	at	50	minutes,	the	Alta	would	vibrate,	cueing	the	participant	to	walk	(~2	
minutes)	to	achieve	her	250	steps	before	the	next	hour.	If	the	hourly	goal	was	met,	on	
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the	dashboard	of	the	Fitbit®	app,	the	gray	circle	would	turn	pink,	indicating	the	goal	
was	met	for	that	hour.	If	the	goal	was	not	met,	the	gray	circle	would	remain	gray,	
indicating	the	goal	was	not	met	(Figure	2).		
	
Figure	2	–	Fitbit®	Group	1	Idle	Alert	Sedentary	Time	App	View	
Group	2	(Walk)	was	asked	to	meet	current	prenatal	PA	recommendations	of	
walking	30	minutes	per	day	on	most	days	of	the	week	(defined	as	5	days	per	week)	to	
accumulate	150	minutes	per	week.7	Group	2	participants	received	a	Fitbit®	Charge	
activity	tracker	and	were	asked	to	record	30-minute	walks	under	the	“track	exercise”	
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feature	of	the	Fitbit®	app.	There	is	no	"reminder	to	move"	function	on	the	Fitbit®	
Charge,	ensuring	participants	randomized	to	this	group	were	not	influenced	by	a	
vibrating	band.	The	Charge	was	worn	on	the	non-dominant	wrist	for	the	entire	
intervention.	It	is	a	fitness	tracker	that	tracks	PA	when	paired	with	an	external	device.81	
Group	2	participants	had	a	Fitbit®	account	set	up	with	a	Blossom	Project	username	
code	to	ensure	privacy	of	the	participant's	identity.	Participants	used	the	app	to	view	
"active	minutes"	(accumulated	activities	in	at	least	10	minutes	at	or	above	3	METs)	
(Figure	3).	
	
Figure	3	–	Fitbit®	Group	2	Active	Minutes	App	View								
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Group	3	(Usual	Care	[UC])	participants	were	not	provided	with	a	Fitbit®	Alta	or	
Charge	activity	monitor;	participants	were	simply	asked	to	continue	with	normal	daily	
routines.	Group	3	did	not	receive	any	intervention	for	four	weeks.		
Physical	activity	assessment	overview	
As	mentioned	previously,	at	baseline	and	final,	participants	wore	two	PA	
monitors	(SWA®	and	AP	TM)	for	the	next	seven	days,	24	hours	per	day	except	when	
showering	or	swimming.	These	were	not	worn	during	the	intervention.	Data	analysis	
was	standardized	to	represent	a	full	seven	days,	24-hour	periods	beginning	and	ending	
at	midnight	on	the	1st	and	7th	day	of	data	collection,	respectively.		
Fitbit®	monitor	
The	company,	Fitbit®,	produces	wrist-worn	PA	monitors	that	track	daily	PA	and	
SB	and	provide	real-time	feedback	on	the	face	of	the	monitor	and/or	when	synced	
wirelessly	to	the	participant’s	phone,	tablet,	computer,	etc.80	These	monitors	require	
charging	every	five	days	to	ensure	track-ability	and	are	worn	on	the	non-dominant	wrist.	
To	ensure	activity	levels	were	not	influenced	by	the	wearing	of	the	monitor,	at	baseline	
and	final,	the	monitor	screen	was	blacked	out	using	black	electrical	tape.	Depending	on	
which	group	participants	were	randomized	to,	for	the	duration	of	the	intervention,	the	
black	electrical	tape	was	removed	and	they	were	provided	with	a	Fitbit®	Alta	(Group	1),	
a	Fitbit®	Charge	(Group	2)	or	no	Fitbit®	(Group	3).	Monitor	utilization	within	each	
group	is	described	in	the	intervention	section	above.	
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SenseWear®	activity	monitor	
The	BodyMedia	SenseWear®	armband	(SWA®)	measures	both	movement	and	
physiological	response	to	estimate	energy	expenditure.	It	is	a	multi-sensory	device	
containing	three	sensors:	accelerometer,	heat	flux	and	galvanic	skin	response	that	is	
worn	over	the	participant’s	left	tricep	for	the	duration	of	the	seven-day	data	collection	
period.82	Data	was	downloaded	using	version	8.0	of	the	BodyMedia	software	(algorithm	
v5.2h).	An	excel	code	was	written	to	categorize	minute	epochs	into	sleep,	sedentary	
(<1.5	METs;	independent	of	nighttime	sleep),	light	(1.6-2.9	METs),	moderate	(3-5.9	
METs)	and	vigorous	(>6	METs)	activity	to	provide	the	estimates	of	total	energy	
expenditure.	Valid	SWA®	data	included	days	with	less	than	90	minutes	of	off	body	time	
(OBT).	For	participants	who	did	not	meet	this	criterion	on	any	given	day,	their	PA	record	
was	utilized	in	order	to	fill	in	the	OBT,	if	possible.	If	the	OBT	could	be	filled	in,	MET	
values	from	the	2011	Compendium	of	Physical	Activity	were	used	to	help	fill	in	the	OBT	
in	the	excel	spreadsheet	containing	the	data.15	For	example,	if	a	woman	was	not	
wearing	her	SWA®	for	95	minutes	due	to	taking	a	bath	(bathing-sitting),	1.5	METs	was	
used	to	fill	in	this	time.	To	do	this,	the	METs	(1.5)	was	multiplied	by	the	amount	of	
minutes	the	armband	was	off	her	body	divided	by	60	minutes	and	multiplied	by	the	
woman’s	weight	in	kilograms.	If	the	woman	weighed	99kg,	the	equation	would	be	as	
follows:	1.5METs*(95/60)*99kg	for	her	energy	expenditure.	The	amount	of	minutes,	in	
this	example,	95	minutes	would	be	filled	in	the	“sedentary”	category	as	bathing-sitting	
has	a	MET	value	of	1.5METs	and	142.5	total	METs	for	this	activity	would	be	filled	in	for	
the	“METs”	category.	Bouts	of	PA	were	also	assessed	using	the	SWA®	data	output.	
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When	analyzing	the	excel	spreadsheet	output	for	each	participant,	a	10-minute	bout	of	
activity	consisted	of	at	least	8	minutes	in	MVPA,	allowing	a	2-minute	gap	in	activity	
within	those	10	consecutive	minutes.	A	20-minute	bout	consisted	of	at	least	16	minutes	
in	MVPA,	allowing	for	no	more	than	a	2-minute	gap	within	a	10-minute	period.	Finally,	a	
30-minute	bout	consisted	of	at	least	24	minutes	in	length	with	no	more	than	a	2-minute	
gap	within	a	10-minute	timeframe.	
activPALTM	monitor	
The	activPALTM	(PALtechnologies,	Scotland,	UK)	accelerometer	monitor	(software	
7.1.18)	provides	insight	into	the	postural	positioning	of	participants	throughout	the	
seven	days	of	data	collection.	This	monitor	classifies	patterns	of	daily	activity	such	as	
standing,	stepping	and	lying	down	and	provides	objective	assessment	of	a	participant’s	
SB.83	Participants	adhered	this	monitor	onto	the	right	quadriceps	muscle	for	the	
duration	of	data	collection	utilizing	APTM	stickies	from	the	company,	PALtechnologies.	
The	women	were	also	provided	with	surgical	tape	and	could	choose	to	use	it	in	order	to	
better	keep	the	monitor	in	place.	Valid	APTM	days	matched	the	days	of	the	valid	SWA®	
days	to	maintain	consistency	within	the	data.	Utilizing	the	excel	spreadsheet	output,	15-
second	epochs	were	analyzed	and	any	period	of	time	greater	than	one	second	during	
which	posture	was	maintained	was	considered	a	bout.	The	APTM	did	not	categorize	sleep	
and	SB	individually.	Therefore,	the	matched	SWA®	data	was	utilized	to	assess	the	time	
in	which	participants	were	awake,	in	order	to	view	SB	during	awake	time	ranges.	The	
output	of	the	APTM	included:	ST,	length	of	sedentary	bouts,	upright	time,	length	of	
upright	bouts,	ST	to	upright	movements	and	upright	to	sedentary	movements.	
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Physical	Activity	Record	(PAR)	
The	PA	record	(PAR)	was	a	log	recorded	by	each	participant	at	baseline	and	final	
for	seven	days,	each.	This	subjective	information	was	used	to	compliment	the	objective	
PA	data	provided	by	the	aforementioned	PA	monitors.	Participants	were	instructed	to	
keep	a	record	of	daily	activities,	including	the	start	and	stop	times	of	each	activity	in	this	
log.	All	activities	were	included	in	this	log,	such	as:	showering,	eating,	driving,	sitting	at	a	
computer,	watching	T.V.,	etc.	This	descriptive	information	allowed	the	OBT	to	be	filled	
in	within	the	SWA®	excel	spreadsheet,	if	feasible	(described	in	the	SWA®	Activity	
Monitor	section,	above).		
Three	Day	Diet	Record	(3DDR)	
Participants	collected	diet	record	information	for	three	of	the	seven	days	of	the	
PA	data	collection.	Participants	were	provided	with	a	digital	scale	and	instructed	to	keep	
track	of	everything	they	ate	for	two	weekdays	and	one	weekend	day	during	this	time	
period.	Participants	were	asked	to	record	the	food	in	grams	immediately	after	weighing	
and	to	be	specific	as	possible	when	describing	the	foods	and	beverages	consumed	(e.g.	
Dole®	diced	peaches	packed	in	100%	fruit	juice).	Diet	records	were	analyzed	for	total	
calorie	intake,	macro	and	micronutrients	utilizing	NutritionistProTM	Diet	Analysis	
software	(Axxya	Systems,	Stafford,	Texas).	The	2010	Healthy	Eating	Index	was	then	used	
to	determine	average	consumption	of	total	fruit,	whole	fruit,	total	vegetables,	dark	
green	vegetables,	beans,	seafood,	plant	protein,	dairy,	grains,	whole	grains,	sodium	and	
empty	calories.	Under-reporting	was	calculated	by	taking	the	ratio	of	a	participant’s	
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average	daily	energy	intake	(Nutritionist	ProTM)	to	energy	expenditure	(SWA®).	If	the	
value	was	<.80	(80%),	the	participant	was	categorized	as	under-reporter.84		
Oral	Glucose	Tolerance	Test	(OGTT)	
At	final,	between	weeks	24-28	of	pregnancy,	participants	completed	a	75-gram,	
2-hour	OGTT	to	assess	glucose	tolerance	and	screen	for	GDM.	The	75-gram	2-hour	
OGTT,	also	known	as	the	one-step	approach,	is	recommended	by	the	American	Diabetes	
Association.46	Participants	were	asked	to	fast	for	at	least	12	hours	prior	to	the	scheduled	
test.	Upon	arrival	at	the	research	center,	participants	had	a	fasted	blood	draw	(7.5mL)	
taken	by	a	trained	phlebotomist.	Participants	consumed	a	75-gram	oral	glucose	
beverage	(McKesson,	San	Francisco,	California)	in	five	minutes.	Venous	puncture	was	
repeated	at	60	and	120	minutes.	Plasma	serum	from	all	three	time	points	were	sent	to	
Quest	Diagnostics	(Madison,	New	Jersey;	headquarters)	to	clinically	assess	glucose	
tolerance.	Table	2	outlines	the	threshold	values	used	to	assess	GDM	in	pregnancy.		
Table	2.	Threshold	Values	to	Diagnosis	Gestational	Diabetes	Mellitus	in	Pregnancy	
Glucose	Measure	 mg/dLa	 mmol/La	
Fasting	Plasma	Glucose	 92	 5.1	
1-hour	plasma	glucose	 180	 10.0	
2-hour	plasma	glucose	 153	 8.4	
aOne	or	more	of	these	values	from	a	75-gram	OGTT	must	be	equaled	or	exceeded	for	the	diagnosis	of	
GDM.46	
	
Participants	also	signed	documents	allowing	for	Blossom	Project	staff	to	send	
OGTT	results	to	their	healthcare	provider,	if	desired.	These	forms	were	then	faxed	to	the	
appropriate	provider.	
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Actiparse	
Actiparse.RB	can	be	utilized	applying	data	from	the	APTM	PA	monitor.	In	order	to	
use	Actiparse	for	each	participant’s	time	point,	an	“awake	range”	file	was	created	in	
excel	that	included	the	approximate	time	the	woman	woke	up	and	went	to	sleep	on	
each	date	at	baseline	and	final.	Time	spent	asleep	was	determined	using	the	SWA®	data	
file.	Following	creation	of	these	awake	ranges	for	seven	days	of	the	data	collection	
period,	the	Actiparse.RB	script	was	used	to	create	an	output.	This	output	produces	
visual	representation	(bar	graphs)	of	average	minutes	per	hour	on	the	y	axis	in	ST	in	60+	
minutes,	50-60	minutes,	40-50	minutes,	30-40	minutes,	20-30	minutes,	10-20	minutes,	
0-10	minutes	and	time	spent	stepping	and	standing	and	hour	increments	of	the	entire	
day	of	the	x	axis	(i.e.	7-8am,	8-9am,	etc.)	(Figure	4).		
Additionally,	bar	graphs	representing	average	minutes/day	spent	sedentary,	
standing	and	stepping	were	produced.	This	time	represents	increments	of	0-10,	10-20,	
20-30,	30-40,	40-50	and	60+	minutes	for	each	graph	(Figure	5).	Finally,	a	percent	wear	
time	in	standing,	stepping	and	ST	was	created	indicating	the	amount	of	time	spent	in	
each	activity	(Figure	6).	
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Figure	4	–	Example	Actiparse	Average	Minutes/Hour	Sedentary,	Standing	and	Stepping	
Output	
	
	
Figure	5	–	Example	Actiparse	Sedentary,	Standing,	Stepping	and	Upright	Time	Output	
	
		
40	
	
Figure	6	–	Example	Actiparse	Percent	Wear	Time	in	Stepping,	Standing	and	Sedentary	
time	Output	
Analysis	
To	determine	if	a	participant	in	Group	1	met	the	intervention	goal,	each	hour	per	
day	the	participant	met	the	goal	was	added	and	totaled	for	one	week	(Fitbit®	data).	The	
amount	of	hours	the	participant	met	the	goal	divided	by	84	hours	per	week	(12	hours	
per	day	multiplied	by	seven	days	per	week)	was	equivalent	to	the	percentage	in	which	
the	intervention	goal	was	met	each	week	for	four	weeks.	To	determine	if	a	participant	in	
Group	2	met	the	intervention	goal,	active	minutes	for	each	day	were	added	and	totaled	
for	one	week	(Fitbit®	data).	The	total	minutes	accumulated	each	week	were	then	
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divided	by	the	goal	of	150	minutes	per	week	to	obtain	the	percentage	of	time	in	which	
the	goal	each	week	for	the	four-week	intervention	was	met.		
	 Data	was	descriptively	examined,	as	the	sample	size	for	this	study	was	small	
(n=8)	and	no	significant	differences	could	be	accurately	detected.	Data	means,	standard	
deviations	and	effect	sizes	were	calculated.	Effect	sizes	were	calculated	by	taking	the	
Group	3	mean	minus	the	intervention	mean	(pooled	together)	and	divided	by	the	
pooled	standard	deviations	(standard	deviations	of	the	usual	care	plus	standard	
deviation	of	the	interventions)	divided	by	two.	Effect	sizes	of	0.2,	0.5	and	0.8	were	
categorized	as	small,	moderate	and	large	effects,	respectively.85	
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CHAPTER	4.	RESULTS	
	
Participants	
	
As	part	of	BUP,	participants	(n=11)	were	randomized	to	one	of	three	groups:	
Group	1	(n	=	5),	Group	2	(n	=	3)	and	Group	3	(n	=	3)	(Figure	7).	Three	women	were	lost	
to	follow-up	(n=1	SenseWear®	armband	sensitivity	issue;	n=2	Jawbone	PA	monitor	was	
initially	utilized	at	the	beginning	of	the	study,	but	transitioned	to	Fitbit®	band	use	for	
the	remainder	of	the	study),	leaving	eight	women	that	completed	the	study.	The	PA	
monitor	transition	occurred	as	the	Fitbit®	provided	more	information	regarding	
participant	SB	and	had	a	reliable	idle	alert	feature.	Participants	(n=8)	were	on	average	
32.9	+	3.6	years	old,	married	(89%),	White	(100%),	and	college	educated	(100%;	
bachelor’s	degree,	50%,	bachelors	and	graduate/professional	degree,	50%).	Participants	
on	average	had	a	pre-pregnancy	body	mass	index	(BMI)	of	28.8kg/m2	(overweight;	BMI	
classifications:	underweight:	n=0;	normal:	n=3;	overweight:	n=1;	obese	I:	n=3;	obese	
class	II:	n=1).	On	average	participants	had	1.75	+	1.2	live	births	while	one	participant	was	
nulliparous.		
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Figure	7	–	BUP	Consort	Diagram	
SB	
Average	total	SB,	reported	as	data	extracted	from	Actiparse,	demonstrates	that	
one	participant	in	each	group	decreased	SB	from	baseline	to	final.	One	participant	in	
Group	1	spent	an	average	of	781.63	+	91.59	minutes	per	day	at	baseline	and	753.24	+	
122	minutes	per	day	at	final	data	collection	in	SB	resulting	in	a	-3.63%	change.	A	
participant	in	Group	2	spent	an	average	of	647.43	+	88.20	minutes	per	day	at	baseline	
and	621.03	+	136.05	minutes	per	day	at	final	data	collection	in	SB,	resulting	in	a	-4.07%	
change.	Finally,	a	participant	in	Group	3	spent	an	average	of	614.68	+	120.24	minutes	
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per	day	at	baseline	and	530.10	+	138.54	minutes	per	day	at	final	data	collection	in	SB,	
resulting	in	a	-13.75%	change	(Figure	8).	This	data	descriptively	demonstrates	that	
despite	the	group	participants	were	randomized	to,	these	three	participants	decreased	
time	spent	sedentary.	
		
Figure	8	–	Individual	Participant	Change	in	Sedentary	Behavior	From	Baseline	to	Final	
Data	Collection	
	
Utilizing	Actiparse,	SB	was	also	broken	up	into	time	spent	sedentary	in	>	60	
minute	bouts.	Data	was	analyzed	in	time	spent	in	bouts	>	60	minutes,	as	previously	
unpublished	Blossom	Project	analysis	demonstrated	an	association	between	prolonged	
bouts	>	60	minutes	and	higher	fasting	blood	glucose	levels.		By	examining	the	data	
descriptively,	when	Group	1	was	asked	to	break-up	prolonged	SB,	this	group,	decreased	
time	spent	in	bouts	of	>	60	minutes	(152.40	+	103.34	minutes	baseline,	133.18	+	19.88	
minutes	final	data	collection).	The	same	is	true	of	Group	2	(202.55	+	60.51	minutes	
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baseline,	175.02	+	89.84	minutes	final	data	collection).	However,	Group	3	(UC)	increased	
time	spent	in	bouts	>	60	minutes	(203.95	+	92.89	minutes	baseline,	224.69	+	132.18	
minutes	final	data	collection)	(Figure	9).	Additionally,	when	examining	effect	size	of	both	
interventions	compared	to	usual	care,	a	moderate	effect	size	was	demonstrated	(0.66).	
	
Figure	9	–	Group	Change	in	Prolonged	Sedentary	Behavior	in	>	60	minute	bouts	
PA	
MVPA	minutes	were	analyzed,	as	the	Department	of	Health	and	Human	Services	
(DHHS)	recommends	150	minutes	of	MVPA	be	accumulated	per	week	during	pregnancy.	
22	On	average,	Group	1	(Idle),	decreased	minutes	of	MVPA	from	baseline	(132	+	96.16	
minutes)	to	final	(40.5	+	34.64	minutes)	data	collection.	On	average,	participants	
collectively	in	Groups	2	(Walk;	16.66	+	22.30	minutes	baseline;	53.66	+	85.27	minutes	
final)	and	3	(UC;	73.33	+	62.26	minutes	baseline;	84.33	+	84.67	minutes	final)	increased	
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PA	of	this	intensity	(Figure	10).	Additionally,	when	comparing	the	intervention	groups	to	
the	usual	care	group,	a	small	effect	size	was	detected	(.48).	
	
Figure	10	–	Group	Change	in	minutes	of	MVPA	
Goal	attainment	for	group	1	and	group	2	(Fitbit®	self-regulation	tool)	
Individuals	in	Group	1	(n=2)	were	asked	to	accumulate	250	steps	per	hour	for	12	
hours	per	day	for	4	weeks	of	the	intervention	(84	total	hours	per	week).	Data	collected	
from	the	participants’	assigned	Fitbit®	demonstrates	that	one	participant	met	the	goal	
>	90.4%	of	the	time	during	the	four-week	intervention.	The	second	participant	in	Group	
1,	met	the	goal	>	58.4%	of	the	time	(Figure	11).	Group	1’s	variability	for	meeting	the	
specified	goal	ranged	from	58.4-98.8%	(minimum;	maximum,	respectively).	
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Figure	11	–	Group	1	Participant’s	Ability	to	meet	the	specified	goal		
Group	2	(n=3)	was	asked	to	meet	current	prenatal	PA	guidelines	and	accumulate	
150	minutes	per	week	for	four	weeks	of	the	intervention.	Data	collected	from	the	
Fitbit®	demonstrates	that	one	participant	in	this	group	met	the	goal	68.6%,	14.6%,	0%	
and	0%	during	weeks	2-5,	respectively.	The	second	participant	exceeded	the	goal	each	
week	evidenced	by	meeting	the	goal	172%,	213%,	138%	and	168%	during	weeks	2-5,	
respectively.	Finally,	the	third	participant	met	the	goal	43.3%,	34.6%,	23.3%	and	57.3%	
of	the	time	during	weeks	2-5,	respectively	(Figure	12).	Group	2	had	a	larger	variability	
(minimum-maximum;	0-213%)	in	regards	to	meeting	the	specified	goal	during	the	four-
week	intervention.	
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Figure	12	-	Group	2	Participant’s	Ability	to	Meet	the	Goal	
Blood	glucose	
Descriptively,	there	appears	to	be	a	positive	relationship	between	increased	SB	
and	higher	fasting,	60	and	120	minute	blood	glucose	levels.	(Figure	13-15).	One	
participant	did	not	pass	the	OGTT	between	24-28	weeks	gestation,	whereas	seven	out	
of	the	eight	participants	did.	Group	3	(UC)	had	the	lowest	fasted	blood	glucose	levels	(83	
+	4	mg/dL)	followed	by	Group	1	(85	+	3	mg/dL)	and	Group	2	(88	+	11	mg/dL),	
respectively.	However,	at	60	and	120	minutes,	respectively,	Group	2	(128	+	32	mg/dL;	
107	+	41	mg/dL)	had	the	lowest	blood	glucose	levels	followed	by	Group	1	(138	+	8	
mg/dL;	116	+	15	mg/dL)	and	Group	3	(150	+	11	mg/dL;	123	+	9	mg/dL).		
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Figure	13	–	All	Participants	Fasted	Blood	Glucose	Values	and	Sedentary	Behavior	
	
	
Figure	14	–	All	Participants	1-Hour	Blood	Glucose	Values	and	Sedentary	Behavior	
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Figure	15	–	All	Participants	2-hour	Blood	Glucose	Values	and	Sedentary	Behavior	
Diet	
Similar	to	blood	glucose	results,	a	positive	relationship	is	present	between	
participants	that	spent	more	time	sedentary	and	increased	calorie	consumption	(Figure	
16).	On	average,	participants	in	Group	2	(Walk)	consumed	the	most	calories	(2150	+	505	
kcal)	followed	by	Group	1	(Idle;	2077	+	38	kcal)	and	Group	3	(UC;	1982	+	1135	kcal)	at	
final	data	collection.	
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Figure	16	–	All	Participants	Calorie	Intake	and	Sedentary	Behavior	
Gestational	weight	gain	
According	to	the	2009	Institute	to	Medicine	(IOM)	weight	gain	guidelines,	one	
participant	was	under	the	recommendation,	one	participant	met	the	recommendation	
and	six	participants	exceeded	the	weight	gain	recommendations	at	final	data	collection.	
By	group	(1,	2,	3)	1	out	of	2,	3	out	of	3,	and	2	out	of	3	participants	exceeded	specified	
IOM	recommendations,	respectively.	When	women	were	randomized	to	Group	2	
(Walk),	all	of	the	participants	(n=3)	exceeded	specified	weight	gain	recommendations	
(Figure	17).		
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Figure	17	–	Participants	Weight	Gain	in	Comparison	to	the	2009	Institute	of	Medicine	
Guidelines	
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CHAPTER	5.	CONCLUSION	
	
Pregnancy	is	a	stage	in	life	in	which	women	have	been	encouraged	to	adopt	
heathier	lifestyles	for	the	benefit	of	both	mother	and	baby.1,	2	A	variety	of	topics	that	
may	influence	healthful	behavior	include:	SB,	PA,	glucose	tolerance,	diet	and	gestational	
weight	gain.3,	4,	43	The	current,	three-armed	randomized	controlled	trial	provided	
information	on	those	aforementioned	subjects.			
Sedentary	Behavior	
The	assessment	of	SB	in	pregnant	women	was	the	primary	outcome	of	this	
study,	as	research	shows	this	behavior	is	associated	with	negative	health	implications.3,	
43	Descriptive	results	from	BUP	demonstrate	despite	the	group	(group	1,	2,	3)	
participants	were	randomized	to,	a	participant	from	each	group	was	able	to	decrease	
SB.	This	yields	the	idea	that	the	approach	pregnant	women	take	to	decreasing	sedentary	
activity	is	individualized	and	one	method	may	not	be	equally	attainable	for	all.	
It	appears	that	participants	in	both	intervention	groups	were	able	to	decrease	
prolonged	SB	in	bouts	>	60	minutes.	Meanwhile,	Group	3	(UC)	increased	prolonged	SB	in	
>	60	minutes,	demonstrating	that	both	interventions	were	successful	at	decreasing	SB	in	
prolonged	bouts,	while	the	participants	that	were	left	to	self-manage,	worsened	this	
prolonged	SB.		This	finding	is	also	supported	by	the	moderate	effect	size	demonstrated	
between	the	interventions	and	usual	care	group.	It	is	important	to	note	that	the	UC	
group	was	not	able	to	decrease	the	pattern	of	prolonged	SB,	as	these	participants	would	
be	less	likely	to	reap	the	benefits	associated	with	breaking	up	this	behavior.	As	
previously	mentioned	research	with	non-pregnant	adults	demonstrates	breaks	in	SB	
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contribute	to	lower	fasting	blood	glucose	levels,	reductions	in	insulin	area	under	curve,	
lower	BMI	and	waist	circumference.10-12	BUP	was	the	first	pregnancy	randomized	
controlled	trial	evaluating	different	strategies	to	decrease	SB.	In	the	non-pregnant	
population,	research	breaking	up	prolonged	sedentary	activity	with	short	walking	breaks	
and	intentional	walking	have	been	carried	out.	Dunstan	et	al.	found	that	when	
participants	rose	to	complete	2-minute	walking	bouts	of	light	or	moderate	intensity	
activity	every	20	minutes,	for	5	hours,	participants	had	lower	glucose	responses	and	a	
reduction	in	iAUC,	compared	to	when	participants	continually	sat	for	5	hours.11	
Additionally,	preliminary	evidence	from	Healy	et	al.	demonstrate	that	breaking	up	
prolonged	bouts	of	sitting	is	beneficially	associated	with	various	health	markers	(e.g.	
BMI,	waist	circumference,	glucose	tolerance	and	triglycerides).	The	authors	call	
attention	to	the	idea	that	benefits	of	breaking	up	prolonged	SB	go	beyond	the	health	
implications	found	in	the	study;	less	time	spent	sedentary	may	mean	more	time	spent	in	
light	and/or	moderate-vigorous	activity.	Hypothetically,	not	only	would	individuals	
decrease	time	spent	sedentary	and	reduce	the	negative	health	implications	associated	
with	SB,	individuals	would	also	increase	PA	and	the	associated	health	benefits.	
Physical	Activity	
MVPA	was	evaluated,	as	the	Department	of	Health	and	Human	Services	
recommends	150	minutes	of	MVPA	be	achieved	each	week.22	In	the	evaluation	of	
MVPA,	a	small	effect	size	was	demonstrated	between	the	interventions	and	usual	care	
group.	Additionally,	Group	1	participants	decreased	minutes	spent	in	MVPA,	whereas	
Group	2	and	Group	3	increased	this	intensity	and	engagement	of	PA.	Group	2’s	increase	
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corresponds	with	the	goal	of	walking	30	minutes	on	most	days	of	the	week	and	is	
positive,	as	45%	of	pregnant	women	report	not	engaging	in	exercise	at	least	three	times	
per	week	during	pregnancy.17	Regarding	PA	interventions	in	pregnancy,	Smith	et	al.	
report	a	significant	(P	<	0.0001)	increase	in	intentional	walking	when	participants	were	
randomized	to	a	behaviorally-based	online	intervention	and	asked	to	walk	at	least	150	
minutes	per	week.	On	average,	31.8%	of	the	intervention	group	met	the	goal	of	
accumulating	at	least	150	minutes	of	PA	per	week,	as	reported	on	the	associated	study	
website.86		Additionally,		in	the	Behaviors	Affecting	Baby	and	You	(BABY)	Study,	
participants	that	were	randomized	to	the	12-week	exercise	intervention	(encouraging	
pregnant	women	to	achieve	at	least	30	minutes	of	moderate-intensity	activity	most	
days	of	the	week),	had	significantly	greater	increases	in	sports	or	exercise	activity	(P	<	
0.001)	and	were	more	likely	to	achieve	guidelines	for	PA	(odds	ratio	=	2.12;	95%	CI	=	
1.45	–	3.10).87	Cumulatively,	this	research	demonstrates	that	when	participants	are	
asked	to	increase	intentional	walking	via	PA	interventions,	participants	have	the	ability	
to	do	so	and	follow	through	with	the	specified	intervention.		
Goal	attainment	for	group	1	and	group	2	(Fitbit®	self-regulation	tool)	
Utilizing	Fitbit®	data,	Group	1	(Idle),	more	easily	met	the	set	goal	(250	steps	per	
hour	for	12	hours	per	day	for	the	four-week	intervention)	than	did	the	walking	group	
(walking	150	minutes	per	week	for	the	four-week	intervention).	This	finding	aligns	with	
the	perceived	barriers	to	PA	women	face	during	pregnancy.	Breaking	up	time	spent	in	
SB	with	short	walks	may	seem	like	a	more	attainable	goal	to	prevent	prolonged	sitting	
as	it	is	likely	to	be	perceived	as	a	less	tasking	and	intimidating	activity	such	that	a	30-
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minute	walk	bears.	Short	bouts	of	walking	avoid	the	reported	PA	barriers	such	as	lack	of	
time,	enjoyment	and	feelings	of	exhaustion.19,	20	Additionally,	insufficient	activity	was	
observed	among	women	who	had	at	least	one	child	in	the	home,	had	a	lack	of	child	care	
and	worked	>	45	hours	per	week.88	To	overcome	these	additional	barriers	to	PA,	
pregnant	mothers	can	utilize	shorts	walks	to	break	up	sedentary	activity	while	at	work	
and	at	home.	Rather	than	taking	a	20-30-minute	walk	away	from	children,	simple	
activities	such	as	getting	up	and	walking	during	commercial	breaks,	getting	up	for	
frequent	bathroom	breaks	and	playing	with	children	rather	than	watching	TV	may	be	
more	attainable	ways	to	decrease	SB	when	a	time	constraint	exists	and	children	are	
present.	
Blood	glucose	
Group	3	(UC)	had	the	lowest	fasting	blood	glucose	levels,	however	at	60	and	120	
minutes,	blood	glucose	levels	were	among	the	highest.	Both	interventions	(Group	1	and	
2)	demonstrated	the	lowest	blood	glucose	levels	at	60	and	120	minutes.	It	is	important	
to	note	the	interventions	may	have	assisted	in	lowering	blood	glucose	levels	at	the	60-	
and	120-minute	mark,	as	keeping	blood	glucose	levels	within	targeted	range	wards	of	
GDM.	Similarly,	when	participants	engaged	in	a	non-fasting	50-gram	OGTT	as	a	part	of	
Project	Viva,	a	sedentary	lifestyle	was	associated	with	abnormal	glucose	tolerance	and	
thus	increased	risk	for	GDM.3	Additionally,	Gollenberg	et	al.	reports	similar	findings	in	
pregnant	Latina	women;	when	participants	engaged	in	high	levels	of	SB,	elevated	
glucose	levels	were	present	at	mid-pregnancy	(24-28	weeks	gestation).60	If	a	GDM	
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diagnosis	can	be	avoided	during	pregnancy,	the	vicious	cycle	of	developing	type	two	
diabetes	mellitus	in	mother	and	baby	post-delivery	can	also	be	halted.	89,	52,	57		
Diet	
In	regards	to	energy	intake,	participants	in	Group	3	(UC)	consumed	the	least	
amount	of	calories	and	Group	2	(Walk)	consumed	the	most	calories.	Women	in	the	
intervention	groups	consumed	more	calories	than	women	randomized	to	the	UC	group.	
Group	2	was	asked	to	meet	current	prenatal	PA	guidelines	of	walking	30	minutes	per	
day	on	most	days	of	the	week.	Similar	to	results	from	another	Blossom	Project	study,	
the	women	who	were	asked	to	increase	intentional	walking	(intervention	group),	also	
inadvertently	increased	calorie	consumption.86	This	information	demonstrates	that	
when	interventions	instruct	women	to	increase	intentional	PA,	a	compensatory	effect	of	
increasing	calorie	consumption	may	occur.	
Additionally,	a	review	authored	by	Blair,	et	al.	reports	that	individuals	who	are	
more	physically	active,	have	higher	calorie	intakes	than	inactive	individuals.90	A	
crossover	study	conducted	by	Finlayson	et	al.	had	non-pregnant	females	engage	in	50	
minutes	of	high-intensity	activity	and	no	exercise	at	all	at	two	different	time	points.	
Energy	intake	was	measured	among	other	subjective	measures.	Although	not	
statistically	significant,	following	exercise,	energy	consumption	at	the	ad	lib	meal	was	
higher	(1128.2	+	72.8	kcals)	than	when	participants	did	not	exercise	(1018.1	+	73.0	
kcals).91	Although	the	reason	for	increased	calorie	consumption	is	not	completely	
understood,	it	may	be,	that	participants	in	these	intervention	groups	felt	they	were	
engaging	in	more	PA,	leading	them	to	believe	they	can/should	consume	more	calories.		
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Limitations	and	future	studies	
Limitations	of	this	study	include	a	small	sample	size	(n=8)	and	little	diversity	
within	the	population	(college	educated,	Caucasian	and	married).	The	intervention	of	
this	study	was	not	performed	during	the	final	week	of	data	collection	(week	6),	as	
participants	were	blinded	to	the	self-monitoring	assessment	tool	(Fitbit®).	Therefore,	
the	true	effects	of	the	intervention	were	not	determined	and	instead,	the	assessment	of	
whether	or	not	the	participants	could	continue	with	the	specified	intervention	was	
evaluated.	Finally,	during	baseline	data	collection,	a	participant	in	group	1	had	the	
Fitbit®	idle	alert	activated,	therefore	her	baseline	data	may	have	been	influenced.	If	this	
study	were	to	be	carried	forward,	to	fully	understand	the	effects	of	the	two	
interventions	(Idle	and	Walk),	the	idle	alert	feature	of	the	Fitbit®	should	be	completely	
deactivated	during	baseline	data	collection	and	participants	should	not	be	blinded	to	
the	self-monitoring	assessment	tool	during	final	data	collection	(week	6).	Additionally,	a	
larger	and	more	diverse	population	would	be	needed	to	better	evaluate	the	most	
effective	strategy	to	reduce	SB	during	pregnancy.		
For	future	studies,	it	would	be	important	to	understand	why	recruitment	was	
difficult	for	BUP	and	how	to	make	a	similar	study	more	attractive	for	potential	
participants.	BUP’s	recruitment	may	have	been	difficult	as	there	were	two	studies	being	
conducted	at	the	same	time	in	The	Blossom	Project	Lab.	One	study	captured	women	
between	10-14	weeks	gestation,	therefore	women	that	could/would	have	been	
interested	in	BUP	were	enrolled	in	a	different	study.	It’s	also	been	suggested	that	
women	dislike	undergoing	two	OGTTs	during	the	same	pregnancy;	one	for	the	research	
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study,	the	other	for	clinical	practice.	If	the	participant’s	provider	did	not	accept	BUP’s	
OGTT	results,	the	woman	typically	needed	to	undergo	an	additional	OGTT	for	her	
provider.	Therefore,	it	may	be	more	beneficial	to	The	Blossom	Project	lab	to	accept	the	
results	of	the	physician;	by	doing	this,	the	lab	decreases	costs	and	the	study	may	
become	more	attractive	to	potential	participants.	Finally,	BUP	was	advertised	as	a	study	
targeting	PA.	If	the	detrimental	effects	of	SB	were	more	heavily	publicized	and	became	
an	even	larger	public	health	concern,	it	may	be	beneficial	to	advertise	future	studies	as	
SB	interventions,	instead	of	PA	interventions,	as	more	women	may	view	an	intervention	
working	to	decrease	SB	as	beneficial	for	not	only	herself	but	her	baby,	as	well.		
Conclusion	
Descriptive	results	from	BUP	suggest	that	when	participants	have	high	sedentary	
time,	more	calories	were	consumed	and	higher	fasting,	60	and	120-minute	blood	
glucose	levels	were	demonstrated.	This	data	indicates	that	when	participants	sat	more,	
calorie	consumption	increased;	a	metabolic	relationship	was	also	present	between	
increased	SB	and	poorer	blood	glucose	levels.	Provided	this	information,	future	studies	
are	needed	to	identify	the	best	strategy	to	decrease	SB	in	pregnant	women.	This	study	
should	be	executed	with	a	larger	sample	size	to	determine	if	breaking	up	prolonged	SB	is	
a	more	successful	method	for	decreasing	this	behavior	throughout	the	day	than	is	
meeting	current	prenatal	PA	guidelines.	It	may	also	be	possible	to	explore	utilizing	
motivational	interviewing	techniques	to	assist	individuals	with	the	goal	of	decreasing	SB.		
Motivational	interviewing	is	a	counseling	style	that	assists	in	eliciting	self-
motivational	statements	from	participants,	with	the	idea	that	individuals	themselves	
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find	the	best	solution	to	facilitate	a	given	behavior	change.92	Regarding	SB,	motivational	
interviewing	may	yield	a	higher	success	rate	than	either	or	both	of	the	proposed	
methods	used	in	BUP	as	it	uses	the	individual’s	own	self-	motivation	and	ideas	regarding	
how	to	successfully	decrease	SB.		
The	study	described	in	this	thesis,	BlossomUP	explored	two	methods	as	ways	to	
decrease	SB	in	pregnant	women.	This	study	helped	continue	to	lay	the	foundation	for	
the	need	of	further	research	regarding	pregnancy	and	SB.	Both	the	use	of	continued	
randomized	controlled	trials	and	possible	implementation	of	motivational	interviewing	
will	continue	to	provide	insight,	advance	the	scientific	literature	regarding	this	topic	and	
has	the	opportunity	to	lead	to	healthier	pregnancies	and	in	turn,	a	healthier	future.		
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Appendix	
APPENDIX	A.	SEDENTARY	BEHAVIOR	AND	PREGNANCY	RESEARCH	STUDIES		
	
Authors	 Population/Location	
&	Design	
Purpose	 Sedentary	Evaluation	 Results	
Oken	et	
al,	2006	
3	
n=1,805	
Prospective	cohort		
Eastern	
Massachusetts	
Associations	
of	PA	and	
TV	viewing	
with	risk	of	
GDM	and	
abnormal	
glucose	
tolerance	
before	and	
after	
pregnancy	
At	initial	visit	(average	of	
10.4	weeks	gestation),	
questionnaire	completed	
evaluating	PA	&	TV	
viewing	habits	over	the	
last	12	months	before	
pregnancy.	At	26-28	
weeks	gestation	the	
same	questionnaire	
regarding	the	last	3	
months	was	completed.	
Sedentary	lifestyle	was	
defined	as	2	or	fewer	
weekly	hours	of	total	PA	
Sedentary	lifestyle	increased	
from	13%	(before	
pregnancy)	to	21%	(during	
pregnancy).	Non-sedentary	
lifestyle	decreased	from	87%	
(before	pregnancy)	to	79%	
(during	pregnancy).	
Television	viewing	for	<	13	
hours	and	>14	hours	
remained	constant	at	66%	
(before	and	during	
pregnancy)	and	34%	(before	
and	during	pregnancy),	
respectively.	Sedentary	
lifestyle	before	and	during	
pregnancy	was	associated	
with	abnormal	glucose	
tolerance	and	risk	for	GDM	
Gollenb
erg	et	
al,	2010	
60	
n=1231		
Prospective	cohort	
Western	
Massachusetts	
	
Association	
between	SB	
and	glucose	
intolerance	
during	
pregnancy	
in	Latina	
women	
Interviewers	utilized	a	
modified	version	of	the	
Kaiser	PA	Survey	
capturing	pre-pregnancy	
(1	year	before	
pregnancy),	early	
pregnancy	(since	
pregnancy	onset)	and	
mid-pregnancy	(24-28	
weeks	gestation)	
behaviors	
High	total	SB	(high	amounts	
of	TV	viewing,	sitting	at	
work,	low	amounts	of	
exercise)	associated	with	
elevated	glucose	during	mid-
pregnancy	(P=0.038).	SB	
during	pre-pregnancy	and	
early	pregnancy	not	
significantly	associated	with	
glucose	levels	
Gradma
rk	et	al,	
201139	
n=108;	35	
pregnant,	73	non-
pregnant	
Cross-sectional	
Sweden	
Evaluate	
insulin	
sensitivity/b
eta	cell	
response	in	
relationship	
to	
subcompon
ents	of	PA	
Actiheart	accelerometer	
worn	4	days	(28-32	
weeks	gestation)	
ST	significantly	higher	in	
pregnant	women	(55.5%	
wear	time)	than	non-
pregnant	women	(49.2%)	
P=<0.0001.	Associations	
between	SB,	insulin	
sensitivity	and	beta	cell	
response	were	not	
significantly	different	
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(including	
SB)	in	
pregnant	
and	non-
pregnant	
women	
between	pregnant	and	non-
pregnant	women	
Evenso
n	et	al,	
201140	
n=359	
Cross-sectional	
United	States;	
NHANES	data	
Examine	PA	
and	SB	in	
pregnant	
women	
Actigraph	accelerometer	
worn	7	days	(average	of	
5.2	months	gestation)	
Average	of	57.1%	of	time	
spent	in	SB.	Average	
sedentary	minutes/day	
during	first,	second	and	third	
trimester:	422.7,	427.6	and	
423.2,	respectively	
Reid	et	
al,	
201423	
n=100	
Parallel-group	
cross-sectional	
Northern	Ireland	
Explore	
relationship	
between	
PA/SB	and	
the	risk	of	
fetal	
macrosomia	
in	
uncomplicat
ed	
pregnancies	
Bodymedia	SenseWear®	
Pro	3	armband	worn	4	
consecutive	days.	
Women	between	26-37	
weeks	gestation	
ST	in	hours	at	<	1MET	was	
16.1	and	13.8,	for	study	
(those	predicted	to	birth	
infants	>4000g)	and	control	
groups	(predicted	to	birth	
infants	<4000g),	
respectively.	Macrosomic	
infants	were	born	to	women	
who	spent	significantly	more	
time	at	<	1METs	than	
women	who	delivered	
infants	<4000g		
Ruifroc
k	et	al,	
201466	
n=111		
Secondary	analysis	
of	data	from	two	
randomized	
controlled	trial	
prospective	studies	
Netherlands	
	
Evaluate	
relationship	
between	
PA/SB	and	
gestational	
weight	gain	
and	birth	
weight	
ActiTrainer	
Accelerometer	worn	
around	15	weeks	and	at	
32-35	weeks	gestation	
Average	SB	min/day	was	530	
and	505	for	15	weeks	and	
32-35	weeks,	respectively.	
No	significant	associations	
found	between	SB	and	GWG	
or	birth	weight	
Di	Fabio	
et	al,	
201541	
n=46	
Prospective	
longitudinal		
Iowa	
Quantify	
and	
evaluate	SB	
and	PA	
during	2nd	
and	3rd	
trimesters	
and	
evaluate	
activity	
habits	for	
women	
SenseWear®	Armband	
and	activPALTM	worn	for	
7	days	during	weeks	18	
and	35	gestation	
SB	during	2nd	and	3rd	
trimesters	stayed	relatively	
consistent	at	52%	and	54%,	
respectively.	No	significant	
differences	at	week	18	in	ST	
between	women	who	met	
PA	guidelines	and	those	that	
did	not,	however	at	week	
35,	women	who	met	PA	
guidelines	engaged	in	
significantly	less	SB	
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meeting	
and	not	
meeting	PA	
guidelines		
Hubert
y	et	al,	
201642	
n=80	
Observational	
study	based	off	of	
randomized	
controlled	trial	data	
Southwestern	
United	States	
Evaluate		
daily	PA	and	
SB	in	
different	
weight	
statuses	of	
pregnant	
women			
Fitbit®	worn	8-16	weeks	
gestation	until	36-40	
weeks	gestation	(or	end	
of	pregnancy)	
Average	sedentary	
minutes/day	993.77,	977.93	
and	961.82	for	normal,	
overweight	and	obese	BMI	
statuses,	respectively.	For	all	
BMI	classifications,	a	trend	
of	increasing	ST	throughout	
pregnancy	was	present	
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APPENDIX	B.	RECRUITMENT	MATERIALS		
	
The Blossom Project Recruiting Email 
Hi 
 
Thank you for your interest in The Blossom Project!  My name is [INSERT NAME 
HERE]     and I am the recruitment coordinator for The Blossom Project at Iowa State 
University. I am replying to you in regards to your inquiry about the project. 
   
The overall objective of The Blossom Project is to assess dietary intake and physical 
activity during pregnancy. We currently have multiple research studies in process, each 
having their own qualification criteria. To help us better assess which research study you 
qualify for, there are a short series of questions that you will be asked to answer, taking 
less than five minutes to complete. 
What are the possible risks and benefits of answering these questions? 
There are no risks associated with answering these questions. By providing answers to 
the questions below, we are able to efficiently screen participants for the research studies 
and minimize the amount of visits you need to make to the research center.  
What measures will be taken to ensure the confidentiality of the responses or to 
protect my privacy? 
Your responses will be kept confidential to the extent allowed by applicable laws and 
regulations. Records will not be made publicly available. However, federal government 
regulatory agencies, auditing departments of Iowa State University (ISU), and the ISU 
Institutional Review Board (a committee that reviews and approves research studies with 
human subjects) may inspect and/or copy your records for quality assurance and analysis.  
These responses may contain private information.  To ensure confidentiality to the extent 
allowed by law, the following measures will be taken. Participant email responses will be 
stored in a specific email folder within the Blossom Project Iowa State University email 
account. This email account is only accessible by password to the Primary Investigator 
and the Recruitment Coordinator. The data obtained from the screening process will be 
regarded as privileged and confidential. 
What are my rights as a human research participant? 
Participating in this screening questionnaire is completely voluntary.  Your choice of 
whether or not to participate will have no impact on you as a student/employee in any 
way (if applicable).  You may skip any question during the questionnaire.  
Whom can I call if I have questions or problems? 
You are encouraged to ask questions at any time.   
 
• For further information about the study contact the recruitment coordinator at 
blossomproject@iastate.edu or the principal investigator Christina Campbell at 
515-294-4260. 
• If you have any questions about the rights of research subjects or research-related 
injury, please contact the IRB Administrator, (515) 294-4566, IRB@iastate.edu, 
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or Director, (515) 294-3115, Office for Responsible Research, Iowa State 
University, Ames, Iowa 50011.  
The following questions will allow us to more efficiently assess which study you qualify 
for. If you are interested in participating in a research study, could you please answer the 
following questions? By replying to this email, you consent to provide this information. 
  
1) Are you between the ages of 18-45? 
2) Are you currently a smoker? 
3) Are you having multiples (ie. twins, etc)? 
4) Do you have any history of chronic disease or blood clotting disorders (type 2 
diabetes, thyroid disorders, heart disease, kidney disease, high blood pressure, etc)? 
5) Prior to becoming pregnant, did you participate in any physical activity outside of your 
normal daily activity? 
6) If so, please summarize your regular weekly activity routine and state how long you 
had been doing this amount of physical activity prior to pregnancy? 
7) What is a phone number at which you could be reached?  
8) How did you hear about The Blossom Project? 
9) Where will you be delivering? 
10) Height:  
11) Pre-pregnancy weight: 
12) Have you been diagnosed with Gestational Diabetes in a previous pregnancy? 
13) Have you been diagnosed with Gestational Diabetes in your current pregnancy? 
14) Have you been diagnosed with pre-eclampsia or eclampsia in a previous pregnancy? 
15) What is your due date?  
 
Thank you and we look forward to hearing from you!  
 
[INSERT NAME HERE]      
Blossom Project: Recruitment Coordinator 
Iowa State University 
blossomproject@iastate.edu 
515-294-8673 
 
ISU IRB #1 11-388 
Approved Date:  22 September 2016 
Expiration Date:  24 September 2017 
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We	are	currently	recruiting	pregnant	women	for	several	research	studies.	General	
qualification	criteria	include	the	following:	
• 18-45	years	old	
• Pregnant	with	only	one	baby	
• Non-smoking	
• No	history	of	chronic	disease	(e.g.	DM1,	CVD,	CRF,	Untreated	thyroid	condition)	
• Able	to	communicate	without	language	or	mental	status	barriers	
	
Participation	is	voluntary.	
Compensation	is	provided	and	varies	based	on	the	study.		
For	further	information	contact	the	Recruitment	Team	at:	
blossomproject@iastate.edu	or	515-294-8673.	
	
ISU	IRB	#1:	11-388	
Approved	Date:	22	September	2016	
Expiration	date:	24	September	2017	
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PREGNANT WOMEN NEEDED! 
 
We	are	conducting	a	research	study	using	physical	activity	to	promote	
improved	health	outcomes	in	pregnant	women.	
	
QUALIFICATION	CRITERIA	INCLUDES:	
•Must	be	pregnant	between	16	and	22	weeks	of	gestation	and	between	the	ages	of	18-
45	
•Not	a	smoker	
•BMI	less	than	40kg/m2	
•Not	pregnant	with	multiple	babies	(e.g.	twins)	
•No	history	of	the	following	chronic	diseases:	Type	1	diabetes,	heart	disease	or	renal	
disease		
•Low-active	or	sedentary	lifestyle	prior	to	pregnancy	(<3	30-minute	intentional	exercise	
sessions)	
•Able	to	comprehend	the	information	shared	during	the	informed	consent	process	
•Approval	from	your	medical	provider	confirming	you	meet	the	qualification	criteria	will	
be	required	
	
	
A	maximum	of	2	data	collection	periods	required.	If	asked,	participant	willing	to	walk	30	
minutes	on	most	days	of	the	week.	Eligible	participants	will	be	compensated.	
Participation	is	voluntary.	
	
	
For	further	information:		
Contact	the	Recruitment	Team	at	blossomproject@iastate.edu	or	515-294-8673	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
ISU	IRB	#	1	15-749	
Approved	Date:	4		January		2017	
Expiration	Date:	4	January	2018	
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“BlossomUP”	
A	program	to	promote	a	physically	active	lifestyle	in	
pregnant	women	
	
WHAT	YOU	MAY	RECEIVE:	
• A	Fitbit	Alta	for	the	duration	of	the	intervention	
• Eligible	participants	may	be	compensated	with	$75.00	in	the	form	of	
cash	and	giftcards	
 
WHAT	YOU	WILL	BE	ASKED	TO	DO:	
• Limit	time	spent	sitting	
• Meet	current	pregnancy	physical	activity	recommendations	
• Continue	with	normal	daily	routine	
	
	
FOR	FURTHER	INFORMATION:	
Contact	the	Recruitment	Team	at	blossomproject@iastate.edu	or	at	515-294-8673	
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Are you or is someone you know 
PREGNANT? 
 
 
 
 
 
The Blossom Project 
“BlossomUP”	
A	program	to	promote	a	physically	active	lifestyle	in	
pregnant	women	
WHAT	YOU	MAY	RECEIVE:	
• A	Fitbit	Alta	for	the	duration	of	the	intervention	
• Eligible	participants	may	be	compensated	with	$75.00	in	the	form	of	
cash	and	giftcards		
WHAT	YOU	WILL	BE	ASKED	TO	DO:	
• Limit	time	spent	sitting	
• Meet	current	pregnancy	physical	activity	recommendations	
• Continue	with	normal	daily	routine	
FOR	FURTHER	INFORMATION:	
Contact	the	Recruitment	Team	at	blossomproject@iastate.edu	or	at	515-
294-8673	
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	 Be	part	of	 	
 The Blossom Project 
 
 
 
 
 
Improving	the	lives	of	women	and	their	babies…	
one	pregnancy	at	a	time	
	
If	you	or	is	someone	you	know	is	PREGNANT,	contact	us.	
We	are	currently	recruiting	for	several	research	studies	
promoting	physical	activity	and	healthful	eating.		
Eligible	participants	will	be	compensated.	Recruitment	is	
ongoing.	
Participation	is	voluntary. 
	
General	Eligibility	Criteria:	
Less	than	22	weeks	pregnant	and	not	pregnant	with	multiples	(e.g.	
twins)	
Not	a	smoker	
Low	level	of	activity	prior	to	pregnancy	(<3	30	minute	exercise	
sessions	per	week)	
	
For	further	information:		
Email	the	Recruitment	Team	at	
blossomproject@iastate.edu	
	or	call	515-294-8673	
ISU	IRB	#	1	11-388	
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Be	part	of	
The Blossom Project 
 
	
Improving	the	lives	of	women	and	their	babies…	
one	pregnancy	at	a	time	
If	you	or	is	someone	you	know	is	PREGNANT,	contact	us.	
We	are	currently	recruiting	for	several	research	studies	promoting	physical	activity	
and		
healthful	eating.		
Eligible	participants	will	be	compensated.	Recruitment	is	ongoing.	
Participation	is	voluntary.	
General	Eligibility	Criteria:	
Less	than	22	weeks	pregnant	and	not	pregnant	with	multiples	(e.g.	twins)	
Not	a	smoker	
Low	level	of	activity	prior	to	pregnancy	(<3	30	minute	exercise	sessions	per	
week)	
For	further	information:		
Email	the	Recruitment	Team	at	blossomproject@iastate.edu	
	or	call	515-294-8673	
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The Blossom Project “BlossomUP” Recruiting Email 
Thank you for your reply! You do indeed qualify for a study that we are currently 
conducting.    
 
Here is more information about this study:   
  
The purpose of this study is to increase physical activity. If you agree to participate in 
this study you will be randomized to one of three groups: 
• Group 1: will be asked to limit time spent sitting 
• Group 2: will be asked to meet current pregnancy physical activity 
recommendations 
• Group 3: will be asked to continue their normal daily routine 
 
During your time in the study you will also be given a Fitbit Alta activity monitor to help 
you keep track of your activity. This is provided to you at no cost. 
 
Individuals in all three groups will fill out various questionnaires related to your medical 
history and/or pregnancy.  At any time you are invited to discuss concerns that you have 
about the study protocol.  
 
You will visit the research center at ISU for 2 data collection periods at the start of week 
one and week six.  
 
During the two data collection periods the following measurements will be taken or 
collected: 
• Weight, 
• Physical activity assessment via 2 activity monitors worn on your arm and thigh 
for 8-days, 
• Dietary assessment by recording the food and beverage that you consume for 3-
days 
• Between weeks 24-28 you will complete a 2-hour oral glucose tolerance test at 
our research facility 
To qualify for our study you must be: 
• Between 18-45 years of age; 
• Pregnant between 16 and 22 weeks of gestation; 
• Not pregnant with multiple babies (e.g. twins);  
• Not a smoker;  
• No history of the following chronic diseases: Type 1 diabetes, heart disease or 
renal disease 
• Low-active or sedentary lifestyle prior to pregnancy (< 3 30-minute intentional 
exercise sessions per week);  
•  BMI less than 40 kg/m2; 
•  Able to comprehend the information shared during the informed consent 
process. 
ISU	IRB	#	1	15-749	
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For your participation, you will receive $75.00 in the form of cash and giftcards following 
completion of the study and return of all equipment.  
I am attaching the consent form which provides more detailed information.  I'll be happy 
to answer any more questions that you may have.   
Please email me at clmck@iastate.edu if you have further questions.  Let me know if 
you would like to participate or not.  If you are interested, please provide me with 
your availability for a 30-45 minute appointment in the next [time period to be 
specified depending upon what is applicable to the specific participant’s current 
gestational length]. 
I look forward to hearing from you soon! 
  
Thanks! 
 
Caroline McKinney 
BlossomUP Study Coordinator 
Iowa State University 
515-294-8673 
clmck@iastate.edu 
blossomproject@iastate.edu 
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CONSENT FORM FOR:	 
THE BLOSSOM PROJECT- “BLOSSOMUP” 
A PROGRAM TO PROMOTE A PHYSICALLY ACTIVE LIFESTYLE IN PREGNANCY 
 
This form describes a research project.  It has information to help you decide whether or 
not you wish to participate. Research studies include only people who choose to take 
part—your participation is completely voluntary.   Please discuss any questions you 
have about the study or about this form with the project staff before deciding to 
participate.   
 
Who is conducting this study? 
     Christina Gayer Campbell, PhD, RD 
     Associate Professor, Nutrition 
     Department of Food Science and Nutrition 
Mailing Address:   220 MacKay Hall 
Physical Address:   1105 Human Nutrition Science Building   
          Iowa State University 
                             Ames, IA 50011-1123          
515-294-4260; ccampbel@iastate.edu 
 
What is the purpose of this study? 
The aim of our study is to increase physical activity in pregnant women. If you agree to 
participate in this study, you will be randomized to one of three groups after you have 
completed the first “baseline” data collection (described below).  Group 1 will be asked to 
sit less each day; Group 2 will be asked to meet current physical activity 
recommendations for pregnant women; Group 3 will continue with their daily routine as 
this is the usual care group.   
 
Why am I invited to participate in this study? 
You are being asked to take part in this study because you are a healthy woman living in 
the communities in and around Ames, IA who has shown interest in our study by 
responding to our recruiting efforts.  You have been selected to participate based on 
several criteria including: 
• Between 18-45 years of age; 
• Pregnant between 16 and 22 weeks of gestation; 
• Not pregnant with multiple babies (e.g. twins);  
• Not a smoker;  
• No history of Type 1 diabetes, heart disease or renal disease 
• Low-active or sedentary lifestyle prior to pregnancy (< 3 30-minute intentional 
exercise sessions per week);  
•  BMI less than 40 kg/m2; 
•  Able to comprehend the information shared during the informed consent 
process. 
 
Regardless of group assignment, what will I be asked to do? 
 
If you agree to participate, you will be asked to do the following: 
ISU IRB # 1 15-749 
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You will be required to receive confirmation that you are healthy enough to participate in 
this study from your medical provider.  At your first visit, you will need to provide contact 
information (including name and phone number) for your medical provider. The attached 
consent letter will be sent by the principal investigator to your medical provider and 
returned via fax to a member of the project staff before you begin any participation in the 
study.  
 
If you are diagnosed with multiple fetuses, or miscarry after enrolling in the study, you 
will no longer be able to participate in the study. If you have any known metal allergies or 
implanted electromagnetic devices you will not be able to participate in this study due to 
possible adverse effects when using the Sensewear® armband monitor.  
 
First week (week 1) and Last week (week 6) of the study: 
 
Your participation in this study will last no more than seven weeks. Baseline data 
collection occurs during week 1 of the study and the second data collection is during the 
last week of the study (week 6). Each data collection period (weeks 1 and 6) requires 
two visits (data initiation [described below] and return of equipment). A data collection 
period is for 8 days (see details below). For each data collection period, you will be 
asked to meet with a member of the project staff at the Nutrition and Wellness Research 
Center (2325 N. Loop Drive #6146, Ames, Iowa) or the facility located on campus in the 
Human Nutritional Sciences Building (HNSB) rooms 2021, 2022, and 2023. For your 
convenience, please provide us with a contact number to facilitate scheduling. The initial 
meeting to receive instructions regarding the physical activity and diet data collection 
and complete the medical questionnaire will last 60-75 minutes; the subsequent data 
initiation meeting will last approximately 30 minutes. 
 
During each data initiation visit (week 1 and week 6 of the study) you will be given two 
activity monitors and the equipment needed to collect a weighed 3-day diet record. Your 
height and weight will be measured. 
 
You will be provided with a SenseWear® Mini physical activity armband that is worn 
on the upper left arm over the triceps muscle.  The activity monitor will be worn for 8 
days, 24 hours a day to ensure the best possible data collection.  The monitor is not 
water resistant and needs to be removed when showering and swimming.  This activity 
monitor has been used in many studies at ISU, including studies with pregnant women, 
with minimal complaints.   
You will be provided with an activPAL™ activity monitor that is worn on the upper leg 
over the quadriceps muscle and will be attached to your leg using an adhesive pad.  The 
activPAL will be worn for 8 days, 24 hours a day except when showering and swimming 
since it is not waterproof. We have previously used this activity monitor in Blossom 
Project studies with minimal complaints. 
The 8-day physical activity record requires you to record all of your daily activities for 
24 hours into a log that will be provided for the same 8- consecutive days you wear the 2 
activity monitors.   
The 3-day food record (3dDR) requires you to weigh and record all food and beverages 
consumed for 2 weekdays and 1 weekend day.  You will be given detailed verbal and 
ISU IRB # 1 15-749 
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written instructions on how to properly complete the forms and tips on accurately 
weighing food.  You will be provided with a dietary scale, at no cost to you, to facilitate 
the process.  You may perceive this to be a tedious process; however it is the most 
accurate means of collecting dietary intake information.   
 
During both initiation visits, you will arrange a time with a project staff member to turn in 
your data collection bag and all materials (all monitors, 3dDR, scale, etc.) at the 
completion of both 8-day data collection period.  
 
 
Prenatal Weight 
Your weight will be measured at your first obstetric prenatal visit by your health care 
provider. Your weight will be recorded on a “Prenatal Weight” form that you will be asked 
to sign at the beginning of the study. Your medical provider will fax the “Prenatal Weight” 
form to the Blossom Project Staff. Additionally, your weight will be measured and 
recorded by a Blossom Project Staff member at week 1, the initial data collection period 
and week 6, at the end of the study. 
 
Six-Week Intervention 
During the six-week intervention, you will be provided with a wrist-worn activity monitor 
called a Fitbit Alta.  You will be asked to wear this daily (remove when showering or 
swimming). A Blossom Project staff member will provide you with a Fitbit account and 
help you set up the application on your external device (e.g. iPhone or laptop) at the 
completion of week 1 baseline data collection and when randomized to a specific group. 
 
Additionally, you will be responsible for charging your Fitbit Alta every five days. If you 
are having any difficulties with your monitor, please contact the Blossom Project staff 
immediately. You will be asked to return the monitor at the completion of the study (week 
6). 
 
Between weeks 24-28 of your pregnancy: 
Oral Glucose Tolerance Test: Data collection will also include completion of an oral 
glucose tolerance test to assess how well your body can decrease sugar from your 
blood; this is a measure of insulin resistance. This is a test that is conducted during all 
pregnancies. Your medical provider may accept the results of our test instead of 
requiring you to complete another; you will need to confirm this with your provider. If you 
would like the Blossom Project Staff to send the results to your medical provider, you will 
need to sign the document, “Request for Oral Glucose Tolerance Test Results” and then 
the research staff can fax the test results to your medical provider.  It is important that 
we conduct our own glucose tolerance test to collect consistent and reliable data since 
this protocol varies between clinics. The oral glucose tolerance test will consist of 
providing a fasted blood sample (following an overnight fast of 10-12 hours), and blood 
samples at 60 and 120 minutes following consumption of a 75g oral glucose solution. 
During this 2-hour period you will be asked to remain seated at the research facility. The 
blood draw will be conducted by a well-trained phlebotomist. Consenting to this study 
allows the investigators to use blood samples for further analysis of glucose and lipid 
metabolism. 
 
If you are randomized to Group 1: 
The idle alert function of your Alta will be activated so you will feel your band vibrate 
every 50 minutes. You are being asked to accumulate 250 steps every hour for 12 hours 
ISU IRB # 1 15-749 
Approved Date: 4 January 2017 
Expiration Date: 4 January 2018 
		
83	
(times will be set based on your waking and bedtime).  
 
If you are randomized to Group 2: 
You are being asked to meet current pregnancy physical activity recommendations; 
walking 30 minutes on most days of the week for a total of 150 minutes per week. You 
will use the app to view your “active minutes”.  
 
If you are randomized to Group 3: 
You are being asked to continue with your normal daily routine. 
 
What are the possible risks and benefits of my participation? 
Risks – There are no foreseeable risks to either you or your fetus by participating in this 
study. The armband used in this study has been used in other studies within our 
laboratory with minimal complaints. A few participants have noted a minor skin irritation 
but it has receded  
 
within a couple of days following discontinued use of the monitor. To avoid skin irritation 
with the Fitbit wrist-worn monitor keep the backside of the monitor and wristband clean. 
Use a cotton ball with rubbing alcohol and gently swipe the metal back of the monitor 
and the portion of the band that touches your skin. Do not immerse the monitor in water. 
Additionally, do not wear the monitor tightly; allow for space between your wrist and the 
monitor.  
 
Benefits – You may increase your physical activity. We hope that this research will 
benefit society by generating data that may contribute to further understanding the 
health benefits of being physically active during pregnancy.  
 
How will the information I provide be used? 
The findings of this study will be shared throughout the scientific community via oral and 
poster presentations at scientific meetings, and published research articles.    
 
Will I incur any costs from participating or will I be compensated? 
There are no direct costs involved with participating in this study, except your cost of 
transportation to and from the research facility (e.g. gas money, bus fare).  You will be 
compensated for participating in this study.  Upon return of all equipment and completion 
of all data collection (six week intervention), you will receive $75.00 in the form of cash 
and giftcards. If your doctor advises you to withdraw from the study following the 
completion of the first data collection period and prior to the final data collection period, 
you will receive $20.00 (if all records are complete).	
 
What measures will be taken to ensure the confidentiality of the data or to protect 
my privacy? 
Records identifying participants will be kept confidential to the extent allowed by 
applicable laws and regulations. Records will not be made publicly available.  However, 
federal government regulatory agencies, auditing departments of Iowa State University, 
and the ISU Institutional Review Board (a committee that reviews and approves 
research studies with human subjects) may inspect and/or copy your records for quality 
assurance and analysis.  These records may contain private information.   
 
To ensure confidentiality to the extent allowed by law, the following measures will be 
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taken: subjects will be assigned a unique code and letter that will be used on forms 
instead of their name. If the results are published, your identity will remain confidential.  
The data obtained from the study will be regarded as privileged and confidential.  Your 
privacy will be maintained in any future analysis and/or presentation of the data with the 
use of coded identifications for each participant’s data.  All data will be stored in a locked 
file cabinet with access only by the principal investigator and project staff. Additionally, 
any data entered into the computer will be available with restricted password only.  This 
data will be kept on hand until the results of the study have been published in a locked 
file in the PI’s laboratory (HNSB 1109).  Identifiers will be kept separate from the data.   
 
What are my rights as a human research participant? 
Participating in this study is completely voluntary.  You may choose not to take part in 
the study or to stop participating at any time, for any reason, without penalty or negative 
consequences.  Your choice of whether or not to participate will have no impact on you 
as a student/employee in any way.  You may skip any question during the medical 
history questionnaire. You may withdraw consent in person or by phone with the 
principal investigator, Christina Campbell at any time.  Please feel free to ask any 
questions or express your concerns regarding this study.  
The investigator will attempt to answer all questions. Contact Dr. Christina Campbell at 
515-294-4260. If by chance any aspect of the data (e.g. physical activity monitors, diet 
record) are returned with compliance (e.g. wear time) deemed insufficient to the primary 
investigator, participation in the study may be terminated.  
What if I am injured as a result of participating in this study?   
 
Emergency treatment of any injuries that may occur as a direct result of participation in 
this research is available at the Iowa State University Thomas B. Thielen Student Health 
Center, and/or referred to Mary Greeley Medical Center or another physician or medical 
facility at the location of the research activity.   
 
Whom can I call if I have questions or problems? 
You are encouraged to ask questions at any time during this study.   
 
• For further information about the study contact the principal investigator Christina 
Campbell at 515-294-4260. 
 
• If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB Administrator, (515) 294-4566, 
IRB@iastate.edu, or Director, (515) 294-3115, Office for Responsible Research, 
Iowa State University, Ames, Iowa 50011.  
 
Consent and Authorization Provisions 
Your signature indicates that you voluntarily agree to participate in this study, that the 
study has been explained to you, that you have been given the time to read the 
document and that your questions have been satisfactorily answered.  You will receive a 
copy of the written informed consent prior to your participation in the study.  
 
Participant’s Name (printed)               
    
ISU IRB # 1 15-749 
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(Participant’s Signature)      (Date)  
 
Investigator Statement 
 
I certify that the participant has been given adequate time to read and learn about the 
study and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this 
study and has voluntarily agreed to participate.    
 
             
      (Signature of Person Obtaining Consent)    
  
ISU IRB # 1 15-749 
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“BlossomUP” 
Dear Medical Provider,  
 
_____________________________ has volunteered to participate in a research study that 
promotes a physically active lifestyle through decreasing sedentary time and increasing 
physical activity. If assigned to group 1, your patient will be asked to reduce sedentary time, 
specifically sitting time, by interrupting prolonged bouts of sitting, as monitored by the Fitbit 
Alta. Participants in group 2 will be asked to increase moderate physical activity by taking a 
30 minute walk on most days of the week. Participants in group 3 will be asked to continue 
their normal daily routine. This is a 6-week intervention. At baseline (week 1) and at the end 
of the study (week 6), your patient will complete an 8-day data collection period. During each 
data collection period, your patient will be weighed, wear a SenseWear® Mini physical 
activity armband, an accelerometer-based posture monitor known as the activPAL and 
complete an 8-day physical activity record and a 3-day weighed food record. Between weeks 
24-28 of pregnancy, she will undergo a 2-hour, 75 gram oral glucose tolerance test to assess 
insulin sensitivity. If your patient would like for us to send the results to you, after obtaining 
her permission, we will do so via fax. 
 
We request you provide us with the participant’s weight at her first prenatal appointment. We 
will fax you an additional form to record the participant’s first prenatal appointment weight on 
and please return the fax to the Blossom Project at Iowa State University. This study is 
approved by the Iowa State University Institutional Review Board.  
  
We would like you to confirm that ______________________________ meets the study 
criteria:  
• Between the ages of 18-45; 
• BMI less than 40 kg/m2; 
• Pregnant with only one baby; 
• Non-smoker;  
• No history of Type 1 diabetes, heart disease or renal disease 
• No physical restrictions to engage in a 30 minute walk most days of the week; 
• Able to comprehend the information shared during the informed consent 
process. 
Signature of Medical 
Provider____________________________________________________________ 
 
Print Name___________________________________________               
Date_____________________ 
 
Please return this form via facsimile as soon as possible.  Thank you for your help with 
this project. 
 
Sincerely,  
Christina Campbell, PhD, RD; Associate Professor, Nutrition; Iowa State University 
Email: ccampbel@iastate.edu; Phone:  515-294-4260; Fax:  515-294-6193 
ISU IRB # 1 15-749 
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BlossomUP Study in Pregnancy Prenatal Weight Form 
 
Dear Medical Provider,  
 
_____________________________ has consented to participating in a study to observe 
total sedentary time and physical activity during their pregnancy. We are asking that you 
provide us with the participant’s weight at the first prenatal appointment, record it on this 
document and fax it to the Blossom Project at Iowa State University. This study is 
approved by the Iowa State University Institutional Review Board.  
 
 
  
Weight of patient at first prenatal appointment _________                             ____  
 
Date of appointment __________________ 
 
 
Signature of Medical 
Provider_______________________________________________________________ 
 
 
Print Name__________________________________________     
Date______________________________ 
 
Please return this form via facsimile as soon as possible.  Thank you for your help with 
this project. 
 
Sincerely,  
 
Christina Campbell, PhD, RD; Associate Professor, Nutrition; Iowa State University 
ccampbel@iastate.edu 
Phone:  515-294-4260 
Fax:  515-294-6193 
 
Signature of research participant providing permission to contact physician & to receive 
her weight:  
 
 
Signature:______________________________ Date: _____________________ 
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Medical History Questionnaire – Blossom Project: BlossomUP 
 
Please answer the following questions to the best of your knowledge.  All 
information provided here is completely confidential.  Please ask for clarification if 
needed. 
 
Subject ID: ____________________   
 
Age: _______yrs_______mo  Date of 
Birth:_____________________________ 
 
Usual Pre-pregnancy weight:_________lbs Height:________ft_________in 
 
Weight when you found out you were pregnant: ____________________lbs 
 
Have you experienced considerable weight gain/loss (5 lbs or more) in the past 6 
months prior to pregnancy?   Yes No  If yes, please 
explain: 
 
________________________________________________________________ 
 
________________________________________________________________ 
 
Handedness:  Right     OR  Left 
 
Is this your first pregnancy?  Yes No 
  
If no, number of pregnancies (including this one)____________________ 
 
Number of live births_____________ 
 
If this is not your first pregnancy and number of pregnancies and live births are 
not equal to each other, please explain: 
________________________________________________________________ 
 
Birth dates of children 
__________________________________________________________ 
   mo/day/yr mo/day/yr mo/day/yr mo/day/yr
 mo/day/yr 
 
Are you planning to breastfeed? Yes  No  Not sure 
 
First day of last menstrual period:__________   
Due Date:__________________________ 
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What is your current due date based on?  LNMP  Ultrasound 
 Other:_________ 
 
What is the first day of your next week of pregnancy (i.e. turnover day)? (circle) 
Sunday     Monday  Tuesday     Wednesday     Thursday     Friday      
Saturday 
 
In what week of your pregnancy did you find out you were 
pregnant?____________________ 
 
Your average number of workouts per week (if any) prior to pregnancy?_______  
 
Average duration of workout_____________________   
 
Type of activity 
___________________________________________________ 
 
Your average number of workouts per week (if any) since becoming 
pregnant?____                   
 
Average duration of workout_____________________   
 
Type of 
activity___________________________________________________ 
Have you experienced any morning sickness that altered your activity level?  
 Yes No 
 
If yes, please 
describe_____________________________________________ 
 
Are you following any guidelines regarding exercise during your 
pregnancy?____________     ___ 
 
If yes, please 
describe_____________________________________________ 
If yes, where did you receive the 
guidelines?_____________________________ 
 
Have you met or seen your medical provider since becoming pregnant?             
Yes No 
  
If yes, please answer the following two questions:  
If no, do you have an appointment scheduled and if so, when?: 
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Has your medical provider discussed exercise during pregnancy with you? 
 Yes No 
  
If yes, please describe his/her recommendations: 
________________________________________________________________
________________________________________________________________ 
 
Has your medical provider discussed weight gain during pregnancy with you? 
 Yes No 
 If yes, please describe his/her recommendations: 
________________________________________________________________
________________________________________________________________ 
 
Race (circle): 
1. American Indian or Alaska Native 
2. African American 
3. Caucasian 
4. Asian 
5. Hispanic 
6. Other (specify):________________ 
 
Marital Status (circle): 
1. single 
2. married 
3. divorced/separated 
4. widowed 
 
Education Level   
What is the highest degree in school that you received?  Please circle: 
1. GED  
2. High School Diploma   
3. Associate’s Degree  
4. Bachelor’s Degree 
5. Graduate or Professional Degree   
6. Other (if none, please specify): 
__________________________________________ 
 
 
Employment: 
What is your occupation?__________________________________ 
If employed how many hours a week do you work?______________ 
 
 
How many adults, age 18 years and older, live in your household? Please 
include yourself. _____________________________________________ 
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How many children, age 17 years and younger, live in your household?  
 
What was your total household gross income in the past year? 
 
1. None   4. $20,001-$30,000  7. $50,001-$75,000  
2. $1-$10,000  5. $30,001-$40,000  8. $75,001 or more 
3. $10,001-$20,000  6. $40,001-$50,000 
 
 
Drug and Alcohol:  
1. Do you currently take vitamin supplements on a regular basis? 
 Yes  No 
If yes, please 
specify___________________________________________________ 
Have you in the past?       
 Yes  No 
If yes, how long 
ago?________________________________________________ 
2. Do you currently take herbal supplements on a regular basis? 
 Yes  No 
If yes, please 
specify___________________________________________________ 
Have you in the past?       
 Yes  No 
If so, how long 
ago?___________________________________________________ 
3. Do you currently take any medications on a regular basis? 
 Yes  No 
If yes, please 
specify___________________________________________________ 
4. Have you taken medication regularly in the past?   
 Yes  No 
If yes, please 
specify___________________________________________________ 
How long ago was medication taken 
regularly?______________________________ 
5.  During your pregnancy are you consuming alcohol?  
 Yes  No 
          If yes, how many drinks each week?_________________________ 
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Medical History (circle any, and give age at diagnosis): 
         Age 
1. Diabetes       ____ 
2. Thyroid Disease     ____ 
3. Cirrhosis      ____ 
4.  Hepatitis      ____ 
5. Gall Stones     ____ 
6. Kidney Stones     ____ 
7.  Nephritis      ____ 
8. Cancer (specify)     ____ 
9.  High Blood Pressure     ____ 
10. Angina      ____ 
11. Allergies (specify)    ____ 
12. Goiter      ____ 
13. Cardiovascular Disease   ____ 
14. Depression requiring medication  ____ 
15. Insomnia requiring medication  ____ 
16. Gestational Diabetes    ____ 
17. Preeclampsia     ____ 
18. Previous infant with low birth weight   ____ 
19. Early delivery with previous pregnancy ____ 
 If so, please explain: 
___________________________________________________________ 
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APPENDIX	D.	TIMEPOINT	DATA	COLLECTION	DOCUMENTS		
	
BlossomUP	Data	Sheet	
	
Subject	ID:	____________________	 	 	 DOB:	
_______________________________	
Due	date:	_____________________	 	 	 Handedness:	
_________________________	
	
Visit	1:	Enrollment	Wks	16-22	
Date:	______________________	 	 	 Gestation	length:	
_____________________	
Height	(cm):	_________________	 	 	 Weight	(kg):	
_________________________	
	
Visit	2:	Wks	24-28	
Date:	_______________________	 	 	 Gestation	length:	
_____________________	
Weight	(kg):	_________________________	 	
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Directions for 3-Day Weighed Diet Record 
 
Ø Please use the scale provided to weigh all food that you eat during your 3 
day recording period. 
 
Ø Keep your food record current.  List all foods and supplements 
immediately after they are weighed.  Do not wait until the end of the day to 
record entries. 
 
Ø Please print all entries. 
 
Ø Be as specific as possible when describing the food or beverage: 
o Include the method of preparation used (boiled, baked, broiled, 
fried, grilled, steamed, raw, etc); example: pork chop, center cut, no 
bone, grilled 
o Include a well detailed description of the food item (fresh, canned, 
packed in heavy or light syrup, packed in water or oil, skinless, 
boneless, cut of meat, brand name); examples: peaches in heavy 
syrup, tuna in oil, broiled T-bone steak, microwave heated canned 
corn 
o Include label with the nutritional information for any unusual items 
or if unsure how to record 
 
Ø Categorize the food consumed by meal type.  Indicate “B” for breakfast, 
“L” for lunch, “D” for dinner, or “S” for snack. 
 
Ø Include the name of restaurant if eating out 
 
Ø Report only the portion of food that was actually eaten; example: T-bone 
steak, grilled -100g (do not include the weight of the bone) 
 
Example:  100g t-bone- 30 g bone=70g actual food consumed 
1- 500 mg multivitamin 
Ø Weigh food left on plate that you did not eat and subtract from original 
total 
 
Ø Record amount in either grams or ounces (wt) –please be consistent 
 
Ø Remember to record condiments (ketchup, soy sauce, mustard, ranch 
dressing, salt, etc) as well as any fats used in cooking (oils, butter, 
margarine, etc), it is acceptable to measure these (Tbsp, tsp etc) 
 
Ø Please try not to alter your normal diet during the period that you keep this 
record …… Thank you!!!!!! 
 
Ø If there are any questions please email:  blossomproject@iastate.edu 
		
	
B/L/D/S	 Time	 Food	 Constituents	 Description	 Weight	
B	 9	am	 Daily	Supplements:	 Multivitamin	 One	a	Day	multivitamin	 1-500	mg	
capsule	
B	 9am	
	
Grape	Nuts	 	 Post	Brand	 120g	
B	 9am	 Sugar	 	 White		 3g	
B	 	
9am	
Milk	 	 1%		 106g	
S	 	
9am	
Blueberries	 	 Frozen,	unsweetened	 50g	
S	 	
9am	
Orange	Juice	 	 Tropicana,	no	pulp,	calcium	added	 120g	
S	 	
11:30	am	
Almonds	 	 Raw,	unsalted,	Kirkland	brand	 60g	
L	 	
1:00pm	
Sandwich	 Bread	 Whole	Wheat,	Wheat	Montana	 45g	
L	 	
1pm	
	 Sprouts	 alfalfa	 5g	
L	 	
1pm	
	 Cheese	 Tillamook	Sharp	Cheddar		 33g	
L	 	
1pm	
	 Ham	 Hillshire	Farms	Honey	Ham	 15g	
S	 	
1pm	
Cottage	Cheese	 	 Low	fat	2%	small	curd	 55g	
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Directions for Activity Monitors 
Ø The SenseWear® armband activity monitor should be placed on the back 
side (over your triceps muscle) of your left arm between the elbow and 
shoulder.  Adjust the strap so if fits your arm comfortably.  Ensure it is 
contact with your skin at all times and that the monitor is right side up on 
your arm (the words should not be upside down when viewed in a mirror). 
 
o There is no on/off button for the activity monitor.  It will be collecting 
data when it is in direct contact with your skin. 
o When the monitor is correctly placed on your arm it will sound off 
“dee dee dee, dee dee”.   
o If the monitor loses contact with your skin or becomes misplaced 
from the proper contact site it will sound off “dee dee dee.”  
Readjust the monitor and listen for the “dee dee dee, dee dee” 
sound to ensure proper placement. 
 
Ø The Fitbit Alta is a wrist-worn fitness tracker that should be worn on the 
non-dominant wrist. 
o The monitor will need to be charged once every 4 days during the 
six week intervention. 
o You are provided with a usb charging cord that connects to a 
computer. 
 
Ø The activPAL activity monitor should be placed on top center of the right 
thigh approximately 1/3 distance down from the hip bone to the top of the 
knee cap. 
o The head of the person on the front of the monitor should be right 
side up.   
 
Ø Please record each activity as you do it in the physical activity log for 7 
days 
o Enter the start and stop time for each activity 
o Include ALL activities throughout your day (showering, eating, 
driving, sitting at computer, watching tv, cooking dinner, walking to 
work, etc.) 
 
Ø After 7 days have passed in week one and week six please be sure to 
make arrangements with a research investigator to return your materials. 
The armband, Fitbit monitor, and activPAL are NOT waterproof!  
Please do not wear them while showering or swimming or submerge 
it in other liquid.   
Thank you. 
**If you develop a skin irritation during the 7 day period, immediately 
contact a research investigator. 
Christina Campbell at 515-520-2326   OR   Caroline McKinney at 
clmdsm@gmail.com 
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Date____________________	
	
Start	
Time	
End	Time	 Activity	 Description	
	
7am		
	
7:30am	
Getting	
dressed/showering	
Up	and	down	stairs	2	to	4	times	
	
7:30	
	
8:00	
Making	and	Eating	
Breakfast	
	
	
8:00	
	
8:25	
	
Drive	to	work	
	
	
8:25	
	
8:30	
	
Walk	from	car	
Quick	walk	from	parking	lot	up	stairs,	one	flight,	to	office	
	
8:30	
	
12:00pm	
	
Working	
Mostly	sitting	at	desk	or	computer		
	
12:00	
	
1:00	
	
Eating	Lunch	
Ate	lunch	and	read	a	magazine		
	
1:00	
	
5:00	
	
Working	
Mostly	sitting	at	desk	or	computer	
	
5:00	
	
5:05	
	
Walk	to	car	
Walk	to	car	in	parking	lot,	down	one	flight	of	stairs	
	
5:05	
	
5:45	
	
Errands	
Walking	around	stores,	and	driving	
	
5:45	
	
6:30	
	
Swimming	
Lap	swim	mostly	freestyle	and	backstroke	about	1000	yards	
	
6:30	
	
7:30	
Making	and	eating	
dinner	
Standing	in	kitchen,	sitting	at	table	
	
For	Official	Use	Only	
Subject	ID:		
Physical	Activity	Log	
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APPENDIX	E.	INSTITUTIONAL	REVIEW	BOARD	APPROVAL	LETTER	
	
	
